the behaviour of deoxynivalenol and deoxynivalenol-3...

51
GHENT UNIVERSITY FACULTY OF PHARMACEUTICAL SCIENCES Department of Bioanalysis Laboratory of Food Analysis Master thesis performed at: WAGENINGEN UNIVERSITY RIKILT Institute of Food Safety BU Contaminants and Toxins Academic year 2012-2013 The behaviour of deoxynivalenol and deoxynivalenol-3-glucoside during the baking process Merel WAEYAERT First Master in Pharmaceutical Sciences: Drug Development Promotor Prof. dr. S. De Saeger Co-promotor Dr. ir. M. De Nijs Commissioners Dr. C. Van Poucke Dr. J. Diana Di Mavungu

Upload: others

Post on 24-Jan-2020

4 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: The behaviour of deoxynivalenol and deoxynivalenol-3 ...lib.ugent.be/fulltxt/RUG01/002/063/851/RUG01-002063851_2013_0001_AC.pdf · is, however, the possibility that deoxynivalenol-3-glucoside

GHENT UNIVERSITY

FACULTY OF PHARMACEUTICAL

SCIENCES

Department of Bioanalysis

Laboratory of Food Analysis

Master thesis performed at:

WAGENINGEN UNIVERSITY

RIKILT – Institute of Food Safety

BU – Contaminants and Toxins

Academic year 2012-2013

The behaviour of deoxynivalenol and

deoxynivalenol-3-glucoside during the

baking process

Merel WAEYAERT First Master in Pharmaceutical Sciences: Drug Development

Promotor

Prof. dr. S. De Saeger

Co-promotor

Dr. ir. M. De Nijs

Commissioners

Dr. C. Van Poucke

Dr. J. Diana Di Mavungu

Page 2: The behaviour of deoxynivalenol and deoxynivalenol-3 ...lib.ugent.be/fulltxt/RUG01/002/063/851/RUG01-002063851_2013_0001_AC.pdf · is, however, the possibility that deoxynivalenol-3-glucoside

COPYRIGHT

"The author and the promoters give the authorization to consult and to copy parts of this thesis

for personal use only. Any other use is limited by the laws of copyright, especially concerning

the obligation to refer to the source whenever results from this thesis are cited."

Promotor Author

Prof. dr. S. De Saeger Merel Waeyaert

Co-promotor

Dr. ir. M. De Nijs

Page 3: The behaviour of deoxynivalenol and deoxynivalenol-3 ...lib.ugent.be/fulltxt/RUG01/002/063/851/RUG01-002063851_2013_0001_AC.pdf · is, however, the possibility that deoxynivalenol-3-glucoside

SUMMARY

Fusarium species (fungi), which grow mainly on crops, cause plant diseases such as

Fusarium head blight (wheat) and Fusarium ear rot (maize). They are able to produce

mycotoxins, which are harmful for the host plant and the animals and humans which consume

these plants. One of these mycotoxins is deoxynivalenol, which causes vomiting, diarrhoea

and nausea when administrated once to animals. In long-term animal experiments, anorexia,

food refusal and immunosuppression was found. Deoxynivalenol has also been linked to

epidemic outbreaks of gastroenteritis-like symptoms among humans after the consumption of

mouldy cereals.

Infected plants have developed defence mechanisms against mycotoxins. One of these is

the metabolisation of the parent molecule to a less toxic derivative. Deoxynivalenol is mainly

converted to deoxynivalenol-3-glucoside and stored in the plant. This derivative is probably

less toxic than deoxynivalenol for the host and consequently for animals and humans. There

is, however, the possibility that deoxynivalenol-3-glucoside might be converted to

deoxynivalenol during processing of the cereals.

This study was elaborated to ascertain the fate of deoxynivalenol and deoxynivalenol-3-

glucoside during bread-making when present in flour. As deoxynivalenol or deoxynivalenol-

3-glucoside might be captured in the matrix during processing, where it would evade

detection, enzymes were used to destroy the matrix. Next liquid chromatography in

combination with tandem mass spectrometry was used to quantitatively determine the

mycotoxins.

The first part of the study was completed, namely to devise an extraction method and to

research the effect of enzymatic matrix digestion on flour. The extraction solvent with the

highest recoveries and least interference for both analytes was acetonitrile and water (50:50,

v:v) with a 1:1 (v:v) dilution with water before injection. Recovery for deoxynivalenol ranged

between 70% and 80%. The recovery of deoxynivalenol-3-glucoside fluctuated during the

study from 60%-70% to 120%. No satisfying cause for this phenomenon was discovered;

degradation of the analyte under these particular circumstances cannot be ruled out. For the

flour matrix, enzymatic matrix digestion did not heighten the recovery of either analyte.

Further research must discover if it might be of use in further steps of the bread-making

process.

Page 4: The behaviour of deoxynivalenol and deoxynivalenol-3 ...lib.ugent.be/fulltxt/RUG01/002/063/851/RUG01-002063851_2013_0001_AC.pdf · is, however, the possibility that deoxynivalenol-3-glucoside

SAMENVATTING

Fusarium species infecteren voornamelijk granen, zowel voor als na de oogst. Daar

veroorzaken ze verschillende plantenziektes zoals fusariumrot, zowel in tarwe als mais. Deze

fungi produceren ook mycotoxines, die gevaarlijk zijn voor de gastheerplant, dieren en

mensen. Een hiervan is deoxynivalenol. Als deze stof eenmalig wordt toegediend aan dieren,

veroorzaakt het nausea, braken en diarree. In lange termijnstudies vertoonden de dieren

verlaagde voedselopname, anorexia en waren meer vatbaar voor infecties. Verschillende

plotse epidemieën waarbij mensen gastro-intestinale symptomen vertoonden zijn gelinkt aan

het eten van beschimmeld graan dat deoxynivalenol bevatte.

Geïnfecteerde planten hebben een aantal verdedigingsmechanismen tegen mycotoxines.

Een mogelijkheid is de omzetting van de moedermolecule naar een minder toxisch derivaat.

deoxynivalenol wordt grotendeels omgezet naar deoxynivalenol-3-glucoside en vervolgens

opgeslagen in de plant. Deze afgeleide molecule is waarschijnlijk niet alleen minder giftig

voor de plant, maar ook voor dieren en mensen. Het is echter mogelijk dat door bewerking

van de granen deoxynivalenol-3-glucoside weer wordt afgebroken tot deoxynivalenol.

Het doel van deze studie was het vaststellen van het lot van deoxynivalenol en

deoxynivalenol-3-glucoside als bloem tot brood wordt verwerkt wanneer de mycotoxines in

het bloem aanwezig zijn. Het kan niet uitgesloten worden dat deoxynivalenol of

deoxynivalenol-3-glucoside gecapteerd wordt in de matrix gedurende dit proces. Daarom

werden enzymen toegevoegd om de matrix te verteren. Vervolgens werden de mycotoxines

gemeten met vloeistof chromatografie gekoppeld aan tandem massa spectrometrie.

De extractiemethode en de enzymatische matrixvertering op meel werden onderzocht. Het

extractiesolvent met de beste resultaten voor beide onderzochte stoffen, zowel op het vlak van

terugvinding als interferentie, was een mix van acetonitrile en bufferoplossing in een (50:50,

v:v) verhouding, die vervolgens met water 1:1 (v:v) verdund werd. De terugvinding voor

deoxynivalenol was tussen de 70% en 80%. De terugvinding van deoxynivalenol-3-glucoside

fluctueerde sterk gedurende de studie: er trad bijna een verdubbeling op van 60%-70% naar

ongeveer 120%. Geen duidelijke oorzaak kon gevonden worden, maar het is mogelijk dat de

stof onder deze omstandigheden langzaam werd afgebroken. Enzymatische matrixvertering

verhoogde de terugvinding niet in bloem. Verder onderzoek zal uitwijzen of deze methode

nuttig is in verdere stappen van het broodbereidingsproces.

Page 5: The behaviour of deoxynivalenol and deoxynivalenol-3 ...lib.ugent.be/fulltxt/RUG01/002/063/851/RUG01-002063851_2013_0001_AC.pdf · is, however, the possibility that deoxynivalenol-3-glucoside

Ik zou graag iedereen bedanken die mij heeft geholpen gedurende het maken van deze

masterproef.

Mijn begeleider Monique, die ondanks haar drukke schema erin slaagde tijd voor mij vrij te

maken en voor de verbeteringen aan het finale werk.

Hester Van den Top, voor haar dagelijkse begeleiding op het labo, haar vrolijkheid en goede

uitleg.

Mijn medestagiairs, voor de gezelligheid en ontspanning: Susannah, Pieter, Larissa, Tjeerd,

Sander, Robbert, Stéphanie, Marlène en Maarten.

Mijn ouders en zus, die, hoewel ze niet lichamelijk aanwezig waren, mentaal een grote steun

waren.

Page 6: The behaviour of deoxynivalenol and deoxynivalenol-3 ...lib.ugent.be/fulltxt/RUG01/002/063/851/RUG01-002063851_2013_0001_AC.pdf · is, however, the possibility that deoxynivalenol-3-glucoside

TABLE OF CONTENTS

COPYRIGHT

SUMMARY

SAMENVATTING

ACKNOWLEDGEMENTS

TABLE OF CONTENTS

LIST OF ABBREVIATIONS

1. INTRODUCTION ........................................................................................................... 1

1.1. MYCOTOXINS ........................................................................................................... 1

1.1.1. Deoxynivalenol ....................................................................................................... 1

1.1.2. Deoxynivalenol-3-glucoside ................................................................................... 3

1.2. INFLUENCES OF PROCESSING ............................................................................. 5

1.2.1. The chemistry behind the recipe .......................................................................... 6

1.2.2. The influence of secondary processing on DON and D3G ................................. 7

1.2.2.1. The influence of secondary processing on DON .............................................. 7

1.2.2.2. The influence of secondary processing on D3G ............................................. 10

1.3. ANALYSIS OF DON AND D3G IN THE BREAD MATRIX ................................ 11

1.3.1. Matrix digestion ................................................................................................... 11

1.3.1.1. Peptidase K ..................................................................................................... 12

1.3.1.2. α-Amylase ....................................................................................................... 12

1.3.1.3. Triacylglycerol lipase ..................................................................................... 13

1.3.2. Extraction and clean-up of DON and D3G ........................................................ 14

1.3.3. Analysis of DON and D3G .................................................................................. 15

2. OBJECTIVES ................................................................................................................ 17

3. MATERIALS AND METHODS .................................................................................. 19

3.1. REAGENTS .............................................................................................................. 19

3.1.1. Chemicals .............................................................................................................. 19

3.1.2. Standards .............................................................................................................. 19

3.1.3. Enzymes ................................................................................................................ 19

3.1.4. Buffer .................................................................................................................... 20

3.2. COLLECTION OF THE SAMPLES ........................................................................ 20

3.3. SAMPLE PREPARATION ....................................................................................... 20

3.3.1. Sample digestion ................................................................................................... 20

Page 7: The behaviour of deoxynivalenol and deoxynivalenol-3 ...lib.ugent.be/fulltxt/RUG01/002/063/851/RUG01-002063851_2013_0001_AC.pdf · is, however, the possibility that deoxynivalenol-3-glucoside

3.3.2. Extraction method ............................................................................................... 21

3.4.1. Standard series ..................................................................................................... 21

3.4.2. Mobile phases ....................................................................................................... 21

3.4.3. LC conditions ....................................................................................................... 22

3.4.4. Mass spectrometry ............................................................................................... 22

3.4.5. Calculations and estimation of the margins of error ........................................ 22

4. RESULTS ....................................................................................................................... 26

4.1. OPTIMISATION OF THE EXTRACTION METHOD ........................................... 26

4.2. OPTIMISATION OF THE MATRIX DIGESTION ................................................. 28

4.2.1. Recovery of DON ................................................................................................. 28

4.2.2. Recovery of D3G .................................................................................................. 29

5. DISCUSSION ................................................................................................................. 32

5.1. EXTRACTION METHOD ........................................................................................ 32

5.2. ENZYME MATRIX DIGESTION ........................................................................... 33

6. CONCLUSIONS ............................................................................................................ 35

7. LITERATURE LIST/REFERENCES ......................................................................... 37

Page 8: The behaviour of deoxynivalenol and deoxynivalenol-3 ...lib.ugent.be/fulltxt/RUG01/002/063/851/RUG01-002063851_2013_0001_AC.pdf · is, however, the possibility that deoxynivalenol-3-glucoside

LIST OF ABBREVIATIONS

15C13 DON Fully C13-labelled deoxynivalenol

3-ADON 3-acetyldeoxynivalenol

15-ADON 15-acetyldeoxynivalenol

ANOVA Analysis of Variance

AOAC Association of Analytical Communities

BRENDA Braunschweig Enzyme Database

D3G Deoxynivalenol-3-glucoside

DNA Deoxyribonucleic acid

DON Deoxynivalenol

DON-GlcA Deoxynivalenol-glucuronide

ECD Electron Capture Detection

EDTA Ethylenediaminetetraacetic Acid

ELISA Enzyme-Linked Immuno Sorbent Assay

ESI Electrospray Ionisation

FAO Food and Agriculture Organisation

GC Gas Chromatography

HPLC High Performance Liquid Chromatography

HSS High Strength Silica

IA(C) Immunoaffinity (Column)

IARC International Agency for Research on Cancer

IgA Immunoglobulin A

IUBMB International Union of Biochemistry and Molecular Biology

JECFA Joint FAO/WHO Expert Committee on Food Additives

LC Liquid Chromatography

LoD Limit of Detection

LoQ Limit of Quantification

LSC Liquid Solid Chromatography

MRM Multiple Reaction Monitoring

MS Mass Spectrometry

m/z Mass-to-charge ratio

PBS Phosphate Buffered Saline

PMTDI Provisional Maximum Tolerable Daily Intake

Page 9: The behaviour of deoxynivalenol and deoxynivalenol-3 ...lib.ugent.be/fulltxt/RUG01/002/063/851/RUG01-002063851_2013_0001_AC.pdf · is, however, the possibility that deoxynivalenol-3-glucoside

QuEChERS Quick, Easy, Cheap, Effective, Rugged, and Safe

RNA Ribonucleic Acid

SCOOP Scientific Cooperation

SD Standard Deviation

S/N Signal-to-Noise ratio

SPE Solid Phase Extraction

TIC Total Ion Chromatogram

UPLC Ultra-high Performance Liquid Chromatography

UV Ultraviolet Detection

WHO World Health Organisation

Page 10: The behaviour of deoxynivalenol and deoxynivalenol-3 ...lib.ugent.be/fulltxt/RUG01/002/063/851/RUG01-002063851_2013_0001_AC.pdf · is, however, the possibility that deoxynivalenol-3-glucoside

1

1. INTRODUCTION

1.1. MYCOTOXINS

All through history, there have been incidents of mycotoxicoses, diseases caused by

mycotoxins in humans and animals. Cases of ergotism have been recorded since the Middle

Ages, when it was referred to as ‘Saint Anthony’s fire’ or ‘holy fire’ and was believed to be a

punishment from God. Some even argued the Salem witch trials were caused by ergot

poisoning (Caporael, 1976). As early as 1891, it was proven in Japan that a beriberi-like

disease known as cardiac beriberi or shoshin kakke was caused by the consumption of

mouldy, yellow rice. Later it was discovered the rice contained a mycotoxin, namely

citreoviridin. In the first half of the twentieth century Russia was plagued by epidemics of

alimentary toxic leukemia, a mycotoxicosis caused by the consumption of overwintered,

mouldy wheat. The true scale of the mycotoxin problem, however, was only fully realised in

1960, when it was discovered that the death of thousands of turkeys was caused by the

ingestion of mycotoxins in their peanut-based feed (Feuell, 1966).

Mycotoxins are secondary metabolites produced by fungi and are toxic to humans and

animals. The fungi producing the most dangerous mycotoxins infect plants in the fields and

greenhouse, or when in storage. Among these, the most important fungal genera producing

mycotoxins are Alternaria, Aspergillus, Fusarium and Penicillium.

1.1.1. Deoxynivalenol

Deoxynivalenol (DON, 12,13-epoxy-3,4,15-trihydroxytrichothec-9-en-8-one, Figure 1.1)

is a mycotoxin produced by Fusarium species. It is most commonly produced by F.

graminearum (common in North and South America, Europe and Asia) and F. culmorum

(common in Europe and Canada), but it is also produced by F. equiseti and F. sambucinum.

These fungi primarily infect small cereals as wheat, maize and barley and cause plant diseases

such as Fusarium head blight (wheat) and Fusarium ear rot (in maize) in the field. Fusarium

head blight often causes weight and size loss of the kernel together with a discolouration

(Figure 1.2).

Apart from disastrous effects on the economy due to yield loss, they also present a major

public health danger (Miller, 1995; Turner, 2010). DON itself was identified in 1972, when

maize infected by F. graminearum caused feed refusal and emesis in pigs.

DON is a member of the trichothecenes, that all share a pyran group, a 9, 10-double bond

and a 12, 13-epoxide. Toxicity and effects differ, however, widely, depending on the various

substituents present. They are therefore classified in four groups: A, B, C and D. All of them

Page 11: The behaviour of deoxynivalenol and deoxynivalenol-3 ...lib.ugent.be/fulltxt/RUG01/002/063/851/RUG01-002063851_2013_0001_AC.pdf · is, however, the possibility that deoxynivalenol-3-glucoside

2

are capable of disturbing the translation of deoxynucleic acid (DNA) by binding ribosomes

and can cause apoptosis in eukaryotic cells (Pestka, 2010). An epidemic outbreak in the

Kashmir Valley in India (1987) was found to be caused by the ingestion of wheat products

which contained high concentrations of various trichothecenes (Bhat et al., 1989).

DON, part of the group B trichothecenes, is considered as one of the lesser toxic

trichothecenes. For example, the international agency for research on cancer (IARC) has

classified it under group 3: not classifiable as to their carcinogenicity to humans (IARC,

1993). Nevertheless it is considered as important, as it is commonly detected in infected

crops, and in processed food and feed, often in high concentrations compared to the other

mycotoxins. Another aspect is the geographic distribution of the toxin: it has been found on

nearly every continent (WHO, 1990; SCOOP, 2003).

The effects of DON, also known as vomitoxin, can be subdivided in two groups: acute

toxicity and chronic toxicity. In humans, it is suggested that DON causes gastroenteritis-like

symptoms with vomiting after a highly DON-contaminated meal. When animal experiments

were performed, the following symptoms were observed: abdominal pain, emesis, diarrhoea

and shock-like death. The latter happened only to mice and rats, animals that are not able to

vomit. When test animals (pigs, mice or rats) were given low doses for an extended period,

Figure 1.1: The molecular structure of deoxynivalenol (Tran and Smith, 2011).

Figure 1.2: Example of cereals infected with Fusarium head blight.

Page 12: The behaviour of deoxynivalenol and deoxynivalenol-3 ...lib.ugent.be/fulltxt/RUG01/002/063/851/RUG01-002063851_2013_0001_AC.pdf · is, however, the possibility that deoxynivalenol-3-glucoside

3

however, the animals stopped gaining weight and became anorexic. It should be noted that

pigs’ symptoms were more severe when they were given naturally contaminated feed and not

when the purified toxin was added to the feed. Another effect of DON is immunotoxicity: a

heightened sensitivity to infections (mice, chickens and pigs), immunoglobulin A (IgA)

nephropathy (mice) and leukocyte apoptosis causing immunosuppression (rodents) were

found in animal studies. DON was also proven to be haemolytic and cytotoxic (a.o. human

adenocarcinoma cells in vitro). Some studies report negative effects on reproduction and

intra-uterine development (Pestka, 2010; JEFCA, 2001).

It is difficult to estimate the chronic, low-dose exposure of humans to the toxin. As

indicated earlier, processed cereal-based foods nearly always contain DON in variable levels.

Aside from this, other aspects such as diet (e.g. vegetarianism), bioavailability and

susceptibility must be taken into account. The food and agriculture organisation and world

health organisation (FAO/WHO) has set the provisional maximum tolerable daily intake

(PMTDI) at 1.00 µg/kg for the sum of DON and its acetylated derivatives, 3- (3-ADON) and

15- acetyldeoxynivalenol (15-ADON) (JECFA, 2010). There have been various studies, most

using DON itself or the sum of DON and DON-glucuronides (DON-GlcAs) as biomarker in

urine, researching the exposure of humans to the toxin. Most found sub-PMTDI levels

(Turner et al., 2010; Turnera et al., 2011; Turnerb et al., 2011), but there was a small study in

Austria were one third of all those examined were above the PMTDI (Warth et al., 2012).

Apart from the rules set by the FAO/WHO, the European Commission has put down a

regulation on the acceptable limits of DON in the following products: unprocessed durum

wheat, oats and maize (1,750 µg/kg); other unprocessed cereals (1,250 µg/kg); cereals meant

for human consumption and uncooked pasta (750 µg/kg); processed cereal-based food (500

µg/kg); and processed cereal-based food targeted at infants and children (200 µg/kg)

(European Commission, Regulation 1881/2006).

1.1.2. Deoxynivalenol-3-glucoside

Generally, derivatives of mycotoxins are indicated with the term ‘masked mycotoxins’,

because they cannot be determined with the conventional methods used for the parent

mycotoxin. Within this group, there are further distinctions: extractable conjugated

mycotoxins, which can be measured if an appropriate standard is available, and bound

mycotoxins, which have to be freed from the matrix before determination (Berthiller et al.,

2013). The terms bound, hidden and masked mycotoxins are often used as synonyms or

confused in different studies, but in this thesis the following definition will be used:

Page 13: The behaviour of deoxynivalenol and deoxynivalenol-3 ...lib.ugent.be/fulltxt/RUG01/002/063/851/RUG01-002063851_2013_0001_AC.pdf · is, however, the possibility that deoxynivalenol-3-glucoside

4

“Bound mycotoxins are covalently or non-covalently attached to polymeric carbohydrate

or protein matrices. Extractable conjugated mycotoxins can be detected by appropriate

analytical methods when their structure is known and analytical standards are available.

Bound mycotoxins, however, are not directly accessible and have to be liberated from the

matrix [...] (Berthiller et al., 2013).”

M

More specifically on the subject of DON, again different types of derivatives can be

discerned. The infected plants can detoxify the mycotoxins, resulting in conjugates such as

deoxynivalenol-3-glucoside (D3G, Figure 1.3). This happens in two phases: in phase I the

mycotoxin is hydrolysed or oxidised, in phase II the resulting molecule is conjugated with a

more polar group. Afterwards, the conjugate is stored in the plant cell, e.g. in the vacuole. It is

assumed that DON can also be bound to a string of glucoside molecules in plants. These are

referred to as DON-oligoglucosides: they explain the rise in D3G that is observed when

brewing beer. A recent study confirmed the presence of DON-oligoglucosides in bread as

well as in beer (Zachariasova et al., 2012).

D3G is less toxic for the plant than its parent molecule. It is found nearly always when

DON is present, usually in lower concentrations. However, more research is devoted to the

possibility of D3G being converted to DON, either during processing or during animal

digestion and metabolism. Also the determination of the altered exposure is being studied.

There have been a few studies focussing on absorption and metabolism (Berthiller et al.,

2011; De Nijs et al., 2012; Nagl et al., 2012). Overall, no reversal to DON was found in the

small intestine and D3G absorption was minimal. Some bacteria species present in the large

bowel can convert D3G to DON (Berthiller et al., 2011); this has been confirmed in a recent

study (Dall’Erta et al., 2013). It should be noted DON absorption is non-existent in the large

intestines. As little is known about its toxicity, no acceptable limits have been established yet,

nor has there been any legislation concerning D3G.

Figure 1.3: The molecular structure of deoxynivalenol-3-glucoside (courtesy of M. De Boevre).

Page 14: The behaviour of deoxynivalenol and deoxynivalenol-3 ...lib.ugent.be/fulltxt/RUG01/002/063/851/RUG01-002063851_2013_0001_AC.pdf · is, however, the possibility that deoxynivalenol-3-glucoside

5

1.2. INFLUENCES OF PROCESSING

The manufacture of cereal-based products with uncleaned cereals as starting point, exists

of two parts: the primary processing and the secondary processing.

In most parts of the world, cereal-based products are a staple food. In developing countries

it often is the main, if not the only part of the diet. Cereals are usually processed before

consumption, at least by such simple actions as cooking. In Western countries, wheat is the

number one cereal used: it is processed to bread, pasta, crackers etc. Therefore, it is not

surprising that, on the subject of DON, wheat is the best studied cereal. Some wheat-based

products such as pasta have the advantage of being cooked before consumption. DON is

water-soluble and therefore a large part, when present, will be discarded with the cooking

water. Unfortunately, this is not customary for every wheat-based product. As bread is in

large parts of the world still the most important staple food, scientific interest is mostly

pointed towards this area. The following section of this study will therefore be devoted to the

making of bread. This process can be divided into two parts, primary and secondary

processing.

The primary processing involves all processing steps used to manufacture flour. It

encompasses cleaning, scouring, segregating and milling of the cereal fractions. The first

three processes can lower the mycotoxin level of the end product, mainly because visibly

infected kernels can be removed. Unfortunately, these fractions often end up in animal feed,

e.g. bran. An effect of infection is often a lower weight and size of the kernel, which means

that selection based on these parameters can lower the DON levels significantly. Also, the

infection by the fungi is mostly localised in the outer parts of the kernel. As more of these

outer parts are removed (e.g. scouring), the amount of DON present is lowered. However, not

all kernels reflect infection in their appearance and a substantial amount of toxin will not be

removed.

The final stage of the primary processing is milling. This also contributes to the removal of

DON, but again not because of destruction of the molecule, but through fractionation. The

highest levels of DON are found in these fractions that are usually not meant for human

consumption, e.g. germ and bran fractions. Furthermore, the finer the flour (i.e. contains less

of the outer parts of the grain), the lesser the DON levels (Kushiro, 2008; Ryu et al., 2008).

The secondary processing, i.e. from flour to bread, includes the making of the dough,

kneading, fermenting, proofing and baking. This research area has been heavily focussed on

in literature, as conclusions on the change in DON and D3G levels vary greatly among

different research groups. Therefore this shall be discussed more in depth below.

Page 15: The behaviour of deoxynivalenol and deoxynivalenol-3 ...lib.ugent.be/fulltxt/RUG01/002/063/851/RUG01-002063851_2013_0001_AC.pdf · is, however, the possibility that deoxynivalenol-3-glucoside

6

1.2.1. The chemistry behind the recipe

Usually, the ingredients of the dough are flour, water, salt, yeast and butter or some form

of fat. These are combined at the start and kneaded. The starch in the flour absorbs the water

and enzymes turn the starch into free sugars. During kneading, more air gets trapped into the

dough and gluten, a product of gliadin and glutenin proteins, is formed. Gluten adds both

plasticity and elasticity, which means that the dough changes form when put under pressure,

but returns to its original shape when that pressure is removed. This allows the dough to rise

and the air bubbles to expand but stops the bubbles in growing when they reach breaking

point.

Yeasts are eukaryotic fungal microorganisms, most commonly of the Saccharomyces

cerevisiae species (also called baker’s or brewer’s yeast). They ferment the sugars formed by

enzymes and produce alcohol and carbon dioxide (CO2) as by-products. The CO2 gets trapped

in the air bubbles in the dough. These bubbles are stabilised by a network of starch and

proteins or by a liquid-lipid film. During fermentation, these bubbles grow and the dough

rises. Often the bread is knocked down and allowed to rise again, which improves flavour.

The final fermenting step is referred to as ‘proving’ and takes place after dividing the dough.

When in the oven, the alcohol and water vaporise and fill holes in the gluten network. This

causes a further rise of the bread, until the crust becomes firm enough to resist growth. The

yeast has died at this point and the gluten are cross-linked: the bread is formed.

Salt is mainly added for the taste. Nevertheless it must be treated with caution, as it can

stop the fermentation process when present in high amounts. In some industrial processes,

additives are added as bread improvers to shorten the fermentation process and improve

dough quality. For example, oxidation-reduction systems are important in the formation of

disulphide bonds in gluten. Therefore oxidising agents, e.g. ascorbic acid (is converted into

dehydroascorbic acid, the true oxidising agent in the dough) and reducing agents, e.g. L-

cysteine, are added. Sometimes enzymes are used as quickening agents, e.g. amylases to

quicken the release of free sugars.

It should be noted that fermenting by yeast is not the only possibility to leave dough,

though it is the most used one. Next to yeasted dough, there is also sourdough, which

incorporates Lactobacillus species besides yeasts. This is a more traditional way of making

bread and needs a long fermentation time. Both sourdough and yeasted dough are biological

ways of leavening. Leavening agents can also be chemical and are then usually a combination

of an acid (e.g. baking soda (sodium bicarbonate)) and an alkali (e.g. cream of tartar

(potassium bitartrate)). Breads produced with leavening agents are usually referred to as quick

Page 16: The behaviour of deoxynivalenol and deoxynivalenol-3 ...lib.ugent.be/fulltxt/RUG01/002/063/851/RUG01-002063851_2013_0001_AC.pdf · is, however, the possibility that deoxynivalenol-3-glucoside

7

breads. Next to biological and chemical leavening, mechanical means can be used to

incorporate air into the dough by beating egg whites (often used in patisserie) or steam-

leavening (as used in popovers). Leavening is not required: there are some unfermented types

of bread. Most types of flatbreads are unleavened, e.g. tortilla (Buehler, 2005; Connelly,

2009; Reuben and Coultate, 2009).

1.2.2. The influence of secondary processing on DON and D3G

There are many contradictory reports in literature regarding the influence of secondary

processing on DON and D3G levels. Some authors report a reduction during the baking step,

others found no change or even an inclination in DON or D3G levels. Comparing these

studies was difficult due to differences in end product (cookies, bread, crackers and type of

bread), ingredients, (traditional) recipe, duration of the steps, the identity of the yeast strain or

temperature. The next subsection will therefore discuss some of these studies more in depth.

1.2.2.1. The influence of secondary processing on DON

The effect of breakmaking on DON has been researched since the eighties. A variety of

studies have focussed on the effect of the different steps, e.g. kneading, fermenting, and not

only on the process as a whole. Some of these studies and their results are summarised in

Table 1.1 (spiked) and 1.2 (natural contamination).

Article Kneaded

dough

Fermented

dough

Proofed

dough Bread Margin of error

Suman et al.,

2012

n.d.c.t.a

flour

n.d.c.t.

previous

stages

n.d.c.t.

previous

stages

rise of 7% to

loss of 54%

no LoDc or LoQd

mentioned

Kostelanska et al.,

2011

5% rise

compared

to flour

n.d.c.t.

previous

stages

n.d.c.t.

previous

stages

13% loss

compared to

flour

LoQ ≤ 5 µg/kg1

Monaci et al.,

2011 -b -

spiking

step

20-30% loss

compared to

spiking

LoD = 0.9 ng/ml

LoQ = 2.8 ng/ml3

Valle-Algarra et al.,

2009 -

n.d.c.t.

flour -

nearly 50%

loss compared

to flour

LoD = 8 µg/kg2

El-Banna et al.,

1983 -

n.d.c.t.

flour -

n.d.c.t.

flour LoD = 0.02 µg/kg1

ano difference compared to; bstep was not researched; climit of detection; dlimit of quantification 1method of calculation not mentioned; 2calculated as 3*S/N (signal-to-noise ratio) and LoQ=3*LoD; 3calculated

as 3 resp. 10 * the SD of the the intercept of the calibration curve

Table 1.1: Literature overview concerning the fate of added DON during the making of bread. If no other

spiking step is named, the DON was added to the flour.

Page 17: The behaviour of deoxynivalenol and deoxynivalenol-3 ...lib.ugent.be/fulltxt/RUG01/002/063/851/RUG01-002063851_2013_0001_AC.pdf · is, however, the possibility that deoxynivalenol-3-glucoside

8

Some research groups focussed on the effect of various additives. Sometimes this was done

to simply find the effect of an additive as used in the industry, others sought purposefully for

a chemical that might lower the amount of DON present. The addition of sodium bisulphate,

L-cysteine and ammonium phosphate to naturally contaminated flour reduced the amount of

DON in the bread (Boyacioglu et al., 1993). The fact that aqueous sodium bisulphate could

lower the detected DON had been discovered before by Young et al. (1986). These authors

used it to lower the DON level during the milling of naturally contaminated flour. They found

however that during the baking, the level of DON rose again, though levels were still lower in

the end product than in untreated flour. The effect of the addition of baking improvers was

researched, but no effect on DON (natural contamination) was found (Kostelanska et al.,

2011). According to one study, yeast, gluten nor starch had any influence on the DON level in

bread baked of naturally-contaminated flour (Ragab et al., 2005).

The effect of certain variables have also been researched. When the stability of DON was

studied under different values for pH and temperature (Lauren and Smith, 2001), only very

harsh conditions (pH > 10, 80 ˚C, several days) brought about any effect. Then again, effect

of temperature on barley powder and roasted kernels showed, next to a protective matrix

effect, a linear reduction of DON in function of the temperature (Yumbe-Guevara et al.,

2003).

Other research groups focussed only on the way of baking as could be found in their own

country. Among others, Lešnik et al. (2008) compared traditional, organic bread-making in

Slovenia with industrial bread-making when naturally-contaminated flour was used and found

no differences in DON reduction. Pacin et al. (2010) used a different approach: instead of

baking themselves, they took samples of both flour and bread in Argentinean bakeries. Both

in Vienna and French bread a reduction of DON was found. The fermentation step in

Argentinean bread made of naturally-contaminated flour (again Vienna and French bread)

was found to significantly lower DON levels, with a maximum of 56% (Samar et al., 2001).

When different conditions (temperature and duration) in Spanish bread-baking were

researched, an overall reduction of 50% DON in comparison to the spiked flour was found

only during the baking step with no difference between the various used conditions (Valle-

Algarra et al., 2009).

Apart from the influence of regional ways of baking, one could also focus on a variety of

different cereals. For instance, the level of DON and D3G were measured in durum wheat in

Italy and the DON level was found to be above regulatory levels (Dall'Asta et al., 2012).

When bread was baked of durum wheat flour (naturally contaminated), an increase in DON

Page 18: The behaviour of deoxynivalenol and deoxynivalenol-3 ...lib.ugent.be/fulltxt/RUG01/002/063/851/RUG01-002063851_2013_0001_AC.pdf · is, however, the possibility that deoxynivalenol-3-glucoside

9

level was measured (de Angelis et al., 2013). In another study, the thermodegradation of

DON in the manufacturing of maize bread was studied (Numanoglu et al., 2012). The

naturally contaminated maize used to manufacture this bread was collected from the Black sea

and Mediterranean regions. One report even differed between naturally contaminated white

and wholemeal flour and absolute values (corrected for dry weight) and corrected (for dry

weight and amount of flour used) values (Scudamore et al., 2009). For white bread, the

absolute value for DON was a reduction, but corrected it gave a risen level. The wholemeal

flour gave a reduction for both the absolute and the corrected values.

Article Kneaded

dough

Fermented

dough

Proofed

dough Bread Margin of error

Bergamini et al.,

2010 -a

only

difference for

low amounts

-

pilot plant:

increase,

industrial:

11% loss

no LoDc or LoQd

mentioned

Abbas et al.,

1985 - - -

16%-60% loss

compared to

flour

LoD = 0.5 ng (GC-

MSe); 10 ng

(HPLC-UVf); DON

as ng/g1

Scott et al.,

1984 - - -

6.7% and 8%

rise compared

to flour

LoD = 0.014 µg/g2

Simsek et al.,

2012 -

50% rise

compared to

flour

n.d.c.t.b

previous

stages

rise of 70%

compared to

flour

no LoD or LoQ

mentioned

El Banna et al.,

1983 - n.d.c.t. flour - n.d.c.t. flour LoD = 0.02 µg/kg1

Ragab et al.,

2005 -

45% loss (~

fermentation

time)

loss of nearly

50% LoD = 0.1 mg/kg1

Lancova et al.,

2008

21%-

40% rise

compared

to flour

38%-46% loss

compared to

flour

32%-

45% rise

compared

to flour

n.d.c.t. flour LoD = 0.5 µg/kg

LoQ = 5 µg/kg1

astep not researched; bno difference compared to; climit of detection; dlimit of quantification; egas

chromatography - mass spectrometry; fhigh performance liquid chromatography - ultraviolet detection 1method of calculation not mentioned; 2calculated as 3*S/N (signal-to-noise ratio)

Some studies took a variety of end products or opted to not research bread. Young et al.

(1986) found a reduction in DON levels (natural contamination) when cookies were made,

however a rise was observed when used for making muffins. Cake, biscuits and crackers were

tested and no effect of baking (only by dilution) was found (Scudamore et al., 2009). In

Table 1.2: Literature overview concerning the fate of DON, present by natural contamination in the flour. All

used naturally contaminated cereals for their research.

Page 19: The behaviour of deoxynivalenol and deoxynivalenol-3 ...lib.ugent.be/fulltxt/RUG01/002/063/851/RUG01-002063851_2013_0001_AC.pdf · is, however, the possibility that deoxynivalenol-3-glucoside

10

another study, the level of DON in cookies, doughnuts and cake was compared to the level in

the flour and the naturally contaminated cereal. All three end products showed a reduction

when compared to the cereal, but hardly any difference compared to the flour. In fact, in the

doughnuts a rise in DON concentration took place, that was masked by the heavy dilution of

the flour (compared to wheat; Young et al., 1984). Doughnuts, pretzels, cookies, bread and

crackers were compared in another report, but only a reduction in DON was found in crackers

and bread (Voss and Snook, 2010). One study focussed exclusively on crackers, to which a

part of the bran (higher DON levels) was added in the dough stage. It showed that when

baking time is lengthened, DON is reduced (Suman et al., 2012).

One research group made a discrimination between the absolute levels of DON, which

were measured with high performance liquid chromatography – ultraviolet detection (HPLC-

UV), and its cytotoxicity according to bioassays. The latter seemed lowered by about 10%

during the baking step in comparison to the naturally contaminated flour, even when the

former remained stable (Sugita-Konishi et al., 2006). This concurred partly with the results of

another study which focussed on degradation products of DON in simple food models: a

significant reduction (up to 50%) of DON was found and the degraded products all possessed

less toxicity (Bretz et al., 2006).

1.2.2.2. The influence of secondary processing on D3G

D3G has not been as widely researched as DON. Three studies that focussed on the effect

of the different bread-making steps have investigated both DON and D3G. Their results for

D3G have been summarised in Table 1.3.

Article Kneaded

dough

Fermented

dough

Proofed

dough Bread

Margin of

error

Suman et al.,

2012

n.d.c.t.a

flour

n.d.c.t.

previous

stages

n.d.c.t.

previous

stages

n.d.c.t. previous

stages

no LoDb or

LoQc

mentioned

Kostelanska et

al., 2011

13% loss

compared

to flour

8% rise

compared

to flour

n.d.c.t.

previous

stages

10% loss

compared to

flour dough

LoQ ≤ 5 µg/kg1

Simsek et al.,

20122 -d n.d.c.t.

flour

slight loss

compared

to flour

loss of 50%

compared to

flour; 42% to

proofed dough

no LoD or LoQ

mentioned

ano difference compared to; blimit of detection; climit of quantification; dstep not researched. 1Method of calculation not mentioned; 2In this study, naturally contaminated wheat was used.

Table 1.3: Literature overview concerning the fate of D3G during the making of bread. If no other

spiking step is named, the D3G was added to the flour.

Page 20: The behaviour of deoxynivalenol and deoxynivalenol-3 ...lib.ugent.be/fulltxt/RUG01/002/063/851/RUG01-002063851_2013_0001_AC.pdf · is, however, the possibility that deoxynivalenol-3-glucoside

11

Kostelanska et al. (2011), who investigated the effect of baking improvers, observed that

the level of D3G increased nearly 50% in proofed dough compared to the naturally

contaminated flour. There was however a subsequent 10% decrease during the baking. The

analysts postulated that the increase was caused by the hydrolysis of DON-oligoglucosides, as

the DON level was not influenced.

In durum wheat, it was found that the D3G concentration was linked to the DON

concentration present (Dall'Asta et al., 2012). De Angelis et al. (2013) found that bread

contained far less D3G than the naturally contaminated durum wheat flour. According to one

study, the lengthening of the baking time of crackers did not influence the D3G levels (Suman

et al., 2012).

1.3. ANALYSIS OF DON AND D3G IN THE BREAD MATRIX

In the next subsections, various methods to quantitatively establish the amount of DON and

D3G will be discussed. Those methods that were used in this study will be mostly focussed

on.

1.3.1. Matrix digestion

As mentioned before, a difference can be made between extractable and bound (non-

extractable) masked mycotoxins. It has been suggested, particularly in those studies where a

rise in DON or D3G was observed after processing, that the bound molecule was released

during processing. When this is reflected upon, it is possible that the reverse might hold true

as well: DON or D3G might be captured in the matrix of the processed food, become

unextractable and cannot be detected. This might be an explanation for those studies where in

an early processing step a loss in the mycotoxin levels was found.

Some studies researched the masked DON present by treating the samples with acid and

comparing the total amount of DON with the amount of free DON found in untreated sample.

Unfortunately, these studies did not take into account the difference between covalently

bound, non-covalently bound and extractable conjugates (Zhou et al., 2008; Tran and Smith,

2011; Tran et al., 2012). Therefore it is not known how much of these found conjugates

represent an actual danger to animal and human health, and how much of it could be found in

the matrix.

Apart from chemical destruction, enzymatic digestion of the matrix is also possible. For

example, the amount of added folic acid in cereal-based products was measured after

treatment of the sample with α-amylase (Osseyi et al., 1998). This was carried out since

hydrolysis of starch heightened the levels of folate detected. Urine was treated with enzymes

Page 21: The behaviour of deoxynivalenol and deoxynivalenol-3 ...lib.ugent.be/fulltxt/RUG01/002/063/851/RUG01-002063851_2013_0001_AC.pdf · is, however, the possibility that deoxynivalenol-3-glucoside

12

in a study that investigated urinary biomarkers and as a result, the levels of mycotoxins

detected rose (Solfrizzo et al., 2011). Nevertheless, most protocols using enzymatic digestion

can be found in bioanalysis of tissues. Such a sample preparation, using collagenase and

proteinase K, was designed to find ingested drugs (Yu et al., 2004). Usually, large molecules

such as DNA, prions or RNA are the target molecules.

The enzymes used in this study, will be discussed in the following subsections.

1.3.1.1. Peptidase K

Peptidase K, more commonly known as proteinase K, is produced by the fungus

Engyodontium album. The enzyme gained its name because of its ability to hydrolyse keratin.

It is a serine endopeptidase, i.e. its active site contains a serine amino acid. Usually,

proteinase K cleaves on the carboxy-side of aliphatic and aromatic amino acids. Both the

temperature and pH range in which the enzyme is stable vary: from 20 °C to 60 °C (maximum

at 37 °C) and from pH 7.5 to 12.0. In addition, its activity is not influenced by commonly

used protein-denaturating chemicals, such as urea or sodium dodecyl sulfate. Calcium is an

activator of the molecule and can be bound in two sites. Nevertheless, proteolytic activity is

preserved (but lowered) in the presence of ethylenediaminetetraacetic acid (EDTA), which

binds calcium. EDTA is often used to eliminate the activity of enzymes that require the

presence.

Because of its stability and broad ligand spectrum, proteinase K is often used to hydrolyse

other enzymes. In nucleic acid purification it hydrolyses nucleases and other enzymes that

might destroy the DNA or ribonucleic acid (RNA) present. Another use is the cleavage of

proteins into peptides that can then be analysed by liquid chromatography – mass

spectrometry (LC-MS) to determine their structure. Among others, prions are often treated

this way (IUBMB, 1992; Sweeney and Walker, 1993).

1.3.1.2. α-Amylase

This enzyme is widespread in animal, fungal and bacterial species. The enzyme hydrolyses

1,4-α-D-glycosidic bonds within oligo- or polysaccharides, producing mono- and

disaccharides. These can be used as carbon sources by the organism that produces the

enzyme. The “α” does not refer to the type of cleavage bond, but to the anomeric

configuration of its product.

Because it is a common enzyme, properties vary greatly. Temperature ranges of activity

can be narrow or broad, pH ranges of activity can be low or high depending on the source of

the enzyme. Because of its use in industrial processes with uncommon pH and temperature

Page 22: The behaviour of deoxynivalenol and deoxynivalenol-3 ...lib.ugent.be/fulltxt/RUG01/002/063/851/RUG01-002063851_2013_0001_AC.pdf · is, however, the possibility that deoxynivalenol-3-glucoside

13

ranges, there are many studies focussing on the search for α-amylases that retain their activity

in these circumstances. Consequently, the pH with the highest stability can be 1 (Bacillus

spp.) to 11 (Streptomyces gulbargensis), and the temperature for activity can vary between 4

°C (Anabaena spp.) to 120 °C (Bacillus spp.) (IUBMB, 1961; BRENDA, EC 3.2.1.1).

The applications of α-amylase in industry are many. It is mainly used in starch conversion

to produce glucose and fructose. This process involves heating and sometimes acid treatment.

The pH often needs to be heightened, however, as the enzymes used in these processes

usually are vulnerable to high temperatures and low pH at the same time. Also, they are often

calcium-dependent. α-Amylases are also used in detergents to remove stains, in ethanol-

biofuel production and in the paper industry. In baking, next to digesting the starch (see

1.2.2.1), it is sometimes added as an anti-staling agent (de Souza and e Magalhães, 2010; Van

Der Maarel et al., 2002). Adding the α-amylase increases the volume, reduces the hardness

and preserves sensory characteristics of the bread. This is probably caused by the enzyme

reducing the starch network and the immobilisation of water (Goesaert et al., 2009; Gomes-

Ruffi et al., 2012).

1.3.1.3. Triacylglycerol lipase

The systematic name of this enzyme is triacylglycerol acylhydrolase. In the presence of

water, triacylglycerols (mostly the outer ones) are converted to diacylglycerols and

carboxylates. The enzyme needs an ester-water interface for activity. Again, this enzyme is

wide-spread, occurring in various bacterial species and in animal species. In the latter, it is

necessary for digestion of lipids, which are an important energy source. Usually, it is

expressed in the adipose tissue, the liver and pancreas. From the latter organ, it is transported

to the gallbladder with other enzymes and then to the small intestine (IUBMB 1961 EC

3.1.1.3; BRENDA EC 3.1.1.3).

In humans, pancreatic lipase needs some extra chemicals, namely bile salts, colipase and

calcium. Bile salts, without colipase present, only enhance the activity of the enzyme in low

concentrations. The bile salts’ function is to aid micelle formation, which facilitate the

digestion of fats. When they are added in high concentrations, they can inhibit this process.

However, this is prevented by the presence of colipase. Colipase also increases the stability of

the lipase. Calcium is also necessary for the activity of lipase, partly because it precipitates

free fatty acids. The latter can inhibit the enzyme (Lessinger et al., 1996; Zangenberg et al.,

2001).

Page 23: The behaviour of deoxynivalenol and deoxynivalenol-3 ...lib.ugent.be/fulltxt/RUG01/002/063/851/RUG01-002063851_2013_0001_AC.pdf · is, however, the possibility that deoxynivalenol-3-glucoside

14

1.3.2. Extraction and clean-up of DON and D3G

For the extraction of DON and D3G, mostly a mix of water and a water-mixable organic

solvent is used. The water present in the extraction solution is supposed to make the grains

swell and enhance extraction (Meneely et al., 2011). Sometimes the organic solvent is

methanol (Suman et al., 2013), but more often acetonitrile is chosen. The ratio is usually

80:20 (v:v) or 84:16 (v:v) acetonitrile:water. Sometimes ammonium acetate and/or acetic acid

is added (Desmarchelier and Seefelder, 2010). Vendl et al. (2009) found that acidic extraction

gave optimal results for a multi-toxin analysis. In some studies, a defatting step was added

(De Boevre et al., 2012).

After a crude extraction, a clean-up step can possibly be added to enhance detection. This

is usually performed with the aid of columns, either solid phase extraction (SPE), e.g.

MycoSep, (Lattanzio et al., 2011; Berthiller et al., 2005), or immunoaffinity columns (IAC;

Suman et al., 2013). SPE has the same basis as liquid solid chromatography (LSC). A liquid

solution containing the target molecule is brought on a column, the solid phase. Elution times

depend on the affinity of the components for the solid phase. IACs also work with a column,

but the solid phase contains antibodies that recognise a specific structure (MacDonald et al.,

2005; Neumann et al., 2009). The problem with the latter method is the often unknown cross-

reactivity. In this case, the antibody-recognised structure is not specific enough and related

structures, e.g. conjugates, also are withheld on the column.

It is possible to use detection systems for which this is not important, e.g. mass spectrometry

(MS), but other methods might not make the distinction between different derivatives.

Consequently, some studies have focussed on the differences and cross-reactivity of

commercially available IACs (e.g. Veršilovskis et al., 2011). In two multi-toxin studies, the

clean-up was investigated. However, because of the low recovery, this method was neglected

(De Boevre et al., 2012; Vendl et al., 2009).

Next to column-clean-up, the QuEChERS (“Quick, Easy, Cheap, Effective, Rugged, and

Safe”) method is a possibility (Desmarchelier and Seefelder, 2010). In this method, originally

developed for multi-pesticide research, salts are added to the extraction mix. These increase

the polarity of the water to such an extent, that phase separation takes place. In theory, the

apolar molecules will prefer the organic solvent and migrate from the water phase. This would

hold true for DON as well. The organic solvent can then easily be separated from the water

and salts. Nevertheless when this method was compared with a MycoSep column for the

detection of DON, T-2- and HT-2-toxins, an enhanced matrix effect was found for DON with

QuEChERS method (Monaci et al., 2011). It was also implied that recovery for D3G might be

Page 24: The behaviour of deoxynivalenol and deoxynivalenol-3 ...lib.ugent.be/fulltxt/RUG01/002/063/851/RUG01-002063851_2013_0001_AC.pdf · is, however, the possibility that deoxynivalenol-3-glucoside

15

low with this method due to its higher polarity (Cirlini et al., 2012). For the same reason,

Dall'Asta et al. (2012) used a methanol-acetonitrile (v:v) mix for their extraction solvent

instead of a acetonitrile-water (v:v) mix.

These extra clean-up steps are becoming less necessary in reference to the higher

sensitivity and quality of the detection systems. The ‘dilute-and-shoot’ approach, in which the

sample only is diluted before injection, gains more attention especially LC-MS/MS (see

under).

1.3.3. Analysis of DON and D3G

For the identification of mycotoxins, a myriad of methods can be chosen. Some of the

detection methods include ultraviolet detection (UV), electron capture detection (ECD) and

MS (Scudamore et al., 2009).

The UV method was investigated in combination with a immunoaffinity clean-up step by

two interlaboratory studies (MacDonald et al., 2005; Neumann et al., 2009) and with post-

column fluorescence derivatisation by another group (Sano et al., 1987).

Before detection, an extra separation step is included, liquid (LC) or gas chromatography

(GC). In GC the molecules are evaporated (mobile phase) and run over a solid or liquid phase

to separate them based on their affinity for the different phases. This used to be a popular

choice for the analysis of DON. However, though GC methods are sensitive and have great

accuracy, they need derivatisation of the components (Meneely et al., 2011). Furthermore,

D3G is far too polar for this technique (Cirlini et al., 2012). Nowadays the LC-MS method is

the more popular, needing very little clean-up and having no necessity for derivatisation

(Lattanzio et al., 2011).

In LC, components are separated by their different affinity for the apolar and polar phases.

One of these is attached to the column and stationary, the other is a liquid mobile phase that

holds the components and is run over the stationary phase. The components distribute

between the two phases depending on their affinity for the stationary phase and elute at

different times. With DON and derivatives, reversed phase LC is mostly used. The preferred

column used is a C18-column with a methanol:water (v:v) or acetonitrile:water (v:v) mobile

phase. As with the extraction mix, ammonium acetate and/or acetic acid can be added

(Suman et al., 2013). Four C18-columns were compared in a study and circumstances were

optimised (Abdel-Aal et al., 2007).

Page 25: The behaviour of deoxynivalenol and deoxynivalenol-3 ...lib.ugent.be/fulltxt/RUG01/002/063/851/RUG01-002063851_2013_0001_AC.pdf · is, however, the possibility that deoxynivalenol-3-glucoside

16

A mass spectrometer (MS) turns the eluting molecules to ions. These are consequently

detected based on their m/z (ratio of mass and ion value) value. The resulting chromatogram

represents the relative intensity of the peaks opposite their m/z value.

In this study, the system used was a tandem mass spectrometry (MS/MS), with a tandem

quadrupole and a collision cell (a third quadrupole) in-between (Figure 1.4). The mode was

multiple reaction monitoring (MRM) which means that after the first selection (of a precursor

ion) in the first quadrupole a fragmentation takes place in the collision cell. This results into

product ions, which can then also be selected in the second quadrupole.

The ionisation technique was electrospray (ESI, Figure 1.4). In this method, the eluent is

forced through a capillary as it comes off the column. At the end of the needle, an electrical

field is placed which nebulises the solution into smaller droplets that all carry multiple

charges. A heated gas is sent through this spray, evaporating part of the solution. The droplets

decrease in size, bringing the identical surface charges closer together. This process is

repeated until the electrical repulsion (known as Coulomb repulsion) between the identical

charges exceeds the surface tension. At this point the droplet explodes into individual,

charged molecules. The advantages of this technique are its ‘soft’ nature, which means

fragmentation is rare, and the fact that it allows the molecules to carry multiple charges.

Figure 1.4: representation of the ionisation technique ESI (left, adapted from Andreas Dahlin from

adorgraphics) and tandem mass spectrometry with a triple quadrupole (right, adapted from

www.broadinstitute.org).

Page 26: The behaviour of deoxynivalenol and deoxynivalenol-3 ...lib.ugent.be/fulltxt/RUG01/002/063/851/RUG01-002063851_2013_0001_AC.pdf · is, however, the possibility that deoxynivalenol-3-glucoside

17

2. OBJECTIVES

Mycotoxins are secondary metabolites produced by fungi. These fungi, mainly Aspergillus,

Fusarium, Alternaria and Penicillium, often grow on cereals in the field. If the infected plants

are insufficiently noticed and subsequently removed, the mycotoxins might end up in food

and feed. As the infection is not always reflected in the plant’s outlook, this happens more

often than suspected. Fusarium species are widespread and can grow in different climates,

occurring nearly all over the world. The fungus can infect a variety of crops, e.g. maize,

wheat.

One of the mycotoxins produced by the Fusarium species is deoxynivalenol (DON), often

in high amounts. This is a mycotoxin that causes abdominal pain, diarrhoea and vomiting in

animals. Epidemic outbreaks of similar symptoms in humans have been linked to the

consumption of grain-based products contaminated with DON. The presence of DON in

cereals seems to be unavoidable. Even when visibly infected kernels are removed, the

mycotoxin can often be detected in the remaining kernels. Although primary processing

(cleaning, scouring and milling of cereals) can remove a certain amount of DON, again the

mycotoxin will still be present in the end products. The highest amounts of DON can be found

in those products that usually are discarded or end up as animal feed, but this hypotheses

DON is also present in products meant for human consumption.

Further problems are caused by the so-called masked mycotoxins. These often originate

from the infected plant. As a detoxification mechanism, the crop forms conjugates of the

mycotoxin and stores it in the plant tissue. Both bound derivatives, which have to be freed

from the matrix before measurement, and extractable, conjugated derivatives may be present

but not detected. In the case of DON, deoxynivalenol-3-glucoside (D3G) is only one example;

the existence of DON-oligoglucosides has been suggested. Those few studies that investigated

the fate of D3G when ingested, found no true risk. Nevertheless there is still the possibility

that processing might convert D3G to DON. There is also the possibility that DON can be

captured in the matrix or be changed (e.g. by micro-organisms) during processing.

Primary processing, which converts the cereals to flour, has proven to lower the amount of

DON when comparing start and end products. However, studies concerning secondary

processing often contradict one another. Furthermore, they often differ in circumstances and

context, making it impossible to compare them. Sometimes values characterising statistical

uncertainty are not mentioned or different formulas are used. This makes it difficult to assess

these studies and their findings.

Page 27: The behaviour of deoxynivalenol and deoxynivalenol-3 ...lib.ugent.be/fulltxt/RUG01/002/063/851/RUG01-002063851_2013_0001_AC.pdf · is, however, the possibility that deoxynivalenol-3-glucoside

18

The goal of the present study is to establish the changes in DON and D3G concentrations

when flour is processed to bread. Several steps in this process are investigated. To ensure that

all DON would be detected and quantified, enzymes are used to digest the bread matrix. This

is performed so even the bound mycotoxin will be included. It also excludes the possibility

that the spiked DON might be captured in the matrix during the processing and not be

detected, though still be harmful to consumer’s health. After digestion, DON and D3G is

extracted from the matrix, using a mix of acetonitrile and water as extraction solvent. The

samples are measured with LC-MS/MS.

Page 28: The behaviour of deoxynivalenol and deoxynivalenol-3 ...lib.ugent.be/fulltxt/RUG01/002/063/851/RUG01-002063851_2013_0001_AC.pdf · is, however, the possibility that deoxynivalenol-3-glucoside

19

3. MATERIALS AND METHODS

3.1. REAGENTS

3.1.1. Chemicals

Acetonitrile ultra LC-MS/MS was obtained from Biosolve BV (Valkenswaard, the

Netherlands) and Actu-All chemicals (Randmeer, the Netherlands). Sodium chloride (NaCl),

potassium chloride (KCl), calcium chloride (CaCl2), disodium hydrogen phosphate dihydrate

(Na2HPO4.2H2O), potassium dihydrogen phosphate (NaH2PO4) and hydrochloric acid (HCl)

were purchased from Merck (Darmstadt, Germany). Magnesium sulfate (MgSO4) and

ammonium acetate (NH4CH3COO) originated from Sigma-Aldrich (Steinheim, Germany).

The water used was purified by a MilliQ© system (Merck Millipore, Massachussets).

3.1.2. Standards

All standards DON, D3G and 15C13-DON were obtained from Biopure (Tulln, Austria).

The D3G stock solution (50.2 µg/mL) and the DON stock solution (100.2 µg/mL) had

acetonitrile as solvent. The internal standard was 15C13-DON (2.51 µg/mL, acetonitrile).

A working solution of DON and D3G was prepared at a concentration of 10 µg/mL as a

spiking solution. This working solution contained 20% D3G stock standard, 10% DON stock

standard and 70% acetonitrile (v:v:v). When necessary, this was replenished by mixing the

same stock solutions in the same ratios. Later in the study this working solution was adjusted

to 5 µg/mL. All solutions were kept in the dark at 2 °C to 8 °C.

3.1.3. Enzymes

All enzymes were purchased from Sigma-Aldrich (Steinheim, Germany). Lipase from

porcine pancreas type II, α-amylase from Bacillus spp., proteinase K from Tritirachium album

(now reclassified as Engyodontium album) and laminarinase from Trichoderma spp. in

powdered form were used. Between use, the enzymes were kept in the dark at -20 °C. The

enzymes were dissolved in the buffer solution (see 3.1.4). Except for laminarinase,

intermediate solutions of these enzymes contained 5 mg/mL, based on an intra-institute

research program. Later in the study, the enzyme concentrations were lowered to 1 mg/mL

without loss of effect. Solutions of enzymes were prepared fresh before use. Laminarinase, a

deconjugation enzyme that can split D3G into a glucose and DON, was made into a 2 mg/mL

solution.

Page 29: The behaviour of deoxynivalenol and deoxynivalenol-3 ...lib.ugent.be/fulltxt/RUG01/002/063/851/RUG01-002063851_2013_0001_AC.pdf · is, however, the possibility that deoxynivalenol-3-glucoside

20

3.1.4. Buffer

The recipe for a phosphate-buffered saline (PBS) with pH 7.4 and calcium was adapted

from Cold Spring Harbor Protocols (June, 2006). The amounts of salts mentioned in Table

3.1 were dissolved in 400 mL water, after which the pH was adjusted to 7.4. The solution was

then diluted to 500 mL. Each time before use, the solution was equilibrated at 37 °C.

For the experiment regarding optimisation of the laminarinase activity, HCl was used to

adjust the pH of the PBS buffer to 5 and 6. Of each pH, 20 mL was prepared.

Chemical Amount (µg)

NaCl 4,000.0

KCl 106.0

Na2HPO4.2H2O 902.1

KH2PO4 119.6

CaCl2 55.1

3.2. COLLECTION OF THE SAMPLES

A variety of flours were purchased in Dutch supermarkets and biological farms in the years

2012 and 2013. These were kept at room temperature in the dark. They were tested for the

presence of DON and D3G and a suitable blank flour was chosen for the rest of the study. In

the rest of this thesis, ‘flour’ will refer to these samples containing this flour. Those samples

that do not contain it, are referred to as ‘blank’.

3.3. SAMPLE PREPARATION

This section implies sample preparation and is most important in studies. It often controls

the recovery of the researched chemical and as such the quality of the entire investigation. In

this study the optimisation of the extraction method gained most attention.

3.3.1. Sample digestion

Enzyme solutions (2 mL) were added separately or together to the samples of 200 mg flour

(‘flour samples’) or empty vials (‘blanks’). After mixing, the samples were incubated for 16

hours at 37 °C on a shaking water bath. Laminarinase was added after this process to several

specific samples that already were digested by the enzymes and allowed to incubate for 30

minutes in a water bath at 37 °C. Different optimal pHs were investigated for laminarinase; in

this part of the study, no other enzymes were added to the mix. These samples were then

again kept in a water bath at 37 °C for half an hour, as described above.

Table 3.1: Amount of chemicals in 0.500 L water for

the manufacture of PBS.

Page 30: The behaviour of deoxynivalenol and deoxynivalenol-3 ...lib.ugent.be/fulltxt/RUG01/002/063/851/RUG01-002063851_2013_0001_AC.pdf · is, however, the possibility that deoxynivalenol-3-glucoside

21

3.3.2. Extraction method

Three possible extraction methods were investigated for flour spiked with DON and D3G.

After spiking, the flour was dried to the air for 30 minutes. The samples were extracted with

buffer, buffer and acetonitrile (20:80, v:v) or buffer and acetonitrile (20:80, v:v) with

QuEChERS (addition of 1.5 g magnesium sulphate and 0.25 g sodium acetate).

The buffer-acetonitrile combination was further optimised. Four concentrations were

tested: 80:20 (v:v) extraction, 50:50 (v:v) extraction, 50:50 (v:v) extraction with afterwards

dilution to 25% acetonitrile with water, and 50:50 (v:v) extraction with evaporation and

redissolvation in eluent A. Evaporation was performed on a Turbovap LV (Biotage, Sweden).

The enzyme samples already contained 2 mL buffer solution; to other samples 2 mL buffer

was added.

After addition of the acetonitrile (2 mL), samples were shaken on a shaking machine SM30

control (Edmund Bühler GmbH, Hechingen, Germany) for 90 minutes at 170 rpm to 200 rpm.

Then the samples were centrifuged at 3,000 rpm for 10 minutes (centrifuge Z513, HERMLE

Labortechnik GmbH, Wehingen, Germany). A small volume (600 µL or 700 µL) of each

sample was placed in a filter vial and placed for 30 minutes at 2 °C to 8 °C before being

filtered. 500 µL was transferred to an HPLC vial and kept by 2 °C to 8 °C until analysis.

3.4. DETECTION: LC AND MS CONDITIONS

3.4.1. Standard series

Standard series in both eluent A and buffer solution were made to accompany sample

injection and to enable the calculation of the concentrations. The standard solutions

mentioned before (3.1.1.) were used. An intermediate solution was made of the DON and

D3G standards with a concentration of 5 µg/mL. This intermediate was used to prepare six

standard levels. The final DON and D3G concentrations in these were 5, 10, 25, 50, 75 and

100 ng/mL. The internal standard 15C13-DON was added to the standard series in eluent A to

become a final concentration of 50 ng/mL.

3.4.2. Mobile phases

For HPLC analysis, two eluents, A and B, were prepared. Eluent A consisted of 5 %

acetonitrile and 95 % water, eluent B of 95 % acetonitrile and 5 % water. Both mobile phases

also contained 1mM of ammonium acetate. The obtained solutions were replenished every

two weeks by mixing of the proper ratios of reagents.

Page 31: The behaviour of deoxynivalenol and deoxynivalenol-3 ...lib.ugent.be/fulltxt/RUG01/002/063/851/RUG01-002063851_2013_0001_AC.pdf · is, however, the possibility that deoxynivalenol-3-glucoside

22

3.4.3. LC conditions

To separate the toxins, the Acquity UPLC© system (Waters, Dublin, Ireland) was used.

The instrument included a sample manager and a binary solvent manager. The column used

was an Acquity HSS (high strength silica) T3 UPLC column (1.8 µm, 2.1 x 100mm) with a

maximum pressure of 1,000 bar (Waters, Dublin, Ireland). This type of column is useful for

the separation of polar components and can tolerate pure water as a mobile phase. The HSS

silica particles can withstand the high pressures that are typical for UPLC.

The column temperature was kept at 50 °C ± 2 °C, the sample temperature was kept at 12

°C ± 5 °C. The flow rate was kept at 0.300 mL/min. Both injection volumes 10 µL as 5 µL

were considered and run time took 13 minutes. The gradient used is described in Table 3.2.

The retention time was 2.55 minutes for D3G and 2.76 for DON.

Time (min) Eluent A (%) Eluent B (%)

0.0 95.0 5.0

1.0 95.0 5.0

7.0 0.0 100.0

11.0 0.0 100.0

11.5 95.0 5.0

13.0 95.0 5.0

3.4.4. Mass spectrometry

The Mass spectrometer (MS) for all experiments was the Micromass Quattro Ultima PT

(Waters, Dublin, Ireland) with MassLynx NTTM Software. The ESI was used in the negative

ionisation mode.

In the ion source, adduct ions may be formed: a combination of an ion and a molecule

which are both present in the solution. In this study, acetate adducts (M + CH3COO-) gave the

best precursor results: 355.10 Da for DON, 370.40 Da for 15C13-DON and 517.30 Da for

D3G. The product ions that were focussed upon were the whole molecules (M-H+):

respectively 295.10, 310.20 and 457.10 Da. The collision energy was 11.00 eV, the cone

voltage was 40.00 V.

3.4.5. Calculations and estimation of the margins of error

When measuring a certain value or concentration, there is always an uncertainty related to

the measured value. The value depends on the circumstances: the used equipment, the

operator and the procedure. Each action has its own uncertainty and adds to the total

uncertainty of the method and eventually to the measured value.

Table 3.2: The gradient used in UPLC.

Page 32: The behaviour of deoxynivalenol and deoxynivalenol-3 ...lib.ugent.be/fulltxt/RUG01/002/063/851/RUG01-002063851_2013_0001_AC.pdf · is, however, the possibility that deoxynivalenol-3-glucoside

23

There are several ways to estimate this uncertainty. The variation in a collection of data

can be described by the standard deviation (variation from the mean in the collection). The

ratio of the standard deviation to the mean is called the relative standard deviation (expressed

as a percentage) and can be used as a representation for the uncertainty of the method.

Further uncertainty can be established by calculating the statistical significance of

differences between values. When two or more flours are analysed for the presence of

mycotoxins, the found values can be compared to find the significant differences between the

samples. The samples can also be compared to a blank sample. Usually a t-test (pair of

samples) or ANOVA (more than a pair of samples) test is used to express uncertainty. When

using these tests, a H0 hypothesis is set forth and challenged (e.g. “all these flours do not

contain mycotoxin, or do not differ from the blank”). When the found values turn out to be

statistically significantly different, the H0 hypothesis is proven wrong (e.g. “these flours differ

from the blank”). In other words, it is highly unlikely that the measurements could occur by

chance. It should be noted that, when using these tests, the formulation of the H0 hypothesis is

of great importance.

Concentrations in samples are often determined by using standard series. This allows

known quantities of the chemical to be linked to a certain response, often pictured in a graph

or in an equation. On this standard series not only the measured values depend, but also the

limit of detection (LoD) and the limit of quantification (LoQ). The LoD is the lowest

concentration that can be discerned from the blank. The LoQ is the lowest concentration that

can be determined. Both can be calculated by multiplying the signal-to-noise ratio (S/N;

response) by three (LoD) or ten (LoQ) and linked to a concentration through the standard

series equation. Other possible calculations are based on multiplication of the standard

deviation of the intercept of the calibration curve or of the calibration curve itself. The latter

method is used by our research institute (RIKILT). This means that the higher the uncertainty

on the standard series equation is, the less reliable the LoD, the LoQ and the determined value

become. The chances of deviations are the highest for the extreme values of the calibration

curve. For this reason it is important that all samples contain amounts of the analyte(s) above

the LoQ and within the concentration range of the standard series.

Usually the uncertainty on the equation and graph is limited by demanding that the

regression coefficient of the standard series equation is higher than 0.9800. This should ensure

that every measurement can only deviate about 20% of the value according to the equation.

Because of the importance of uncertainty on the totality of the study, all parameters

influencing this factor should be controlled as much as possible. It is also important to report

Page 33: The behaviour of deoxynivalenol and deoxynivalenol-3 ...lib.ugent.be/fulltxt/RUG01/002/063/851/RUG01-002063851_2013_0001_AC.pdf · is, however, the possibility that deoxynivalenol-3-glucoside

24

uncertainty values and how they were established in studies so others can assess the

importance and correctness of it. This is however not always remembered when a study is

written down. When taking the eleven studies, previously described in Tables 1.1 to 1.3, three

studies did not mention an LoD or LoQ. Three studies mentioned both, four mentioned only

the LoD and one only the LoQ. Only three out of eleven studies specified the calculation

method; only one of these used the multiplication of the standard deviation of the intercept of

the calibration curve. The other two used the multiplication of S/N.

The goal of this master thesis was not method development, nor validation. Therefore, the

LoD and LoQ was recalculated for every standard series that was injected and never formally

established. To obtain the LoQ, the standard error of the standard series graph was multiplied

by three. The intercept was subtracted from this value and the result was divided by the slope

(see Calculation 3.1 below). The LoQ was divided by three to give the LoD (Calculation

3.2).

𝐿𝑜𝑄 =3∗𝑆𝐸−𝑏

𝑎 (3.1)

with: LoQ = limit of quantification;

SE = standard error of the standard series equation;

b = intercept of the standard series equation;

a = slope of the standard series equation.

𝐿𝑜𝐷 = 𝐿𝑜𝑄

3 (3.2)

with: LoD = limit of detection.

Often in studies, the LoD and LoQ concentration is converted to w:w values (mass of

analyte compared to mass of flour). A generic example of such a calculation would be:

𝐿𝑜𝑋 (𝑤/𝑤) =𝐿𝑜𝑋∗𝑑𝑓∗𝑉𝑒𝑥𝑡𝑟𝑎𝑐𝑡𝑖𝑜𝑛

𝑤𝑓𝑙𝑜𝑢𝑟 (3.3)

with: LoX = LoD or LoQ (e.g. ng/mL);

df = dilution factor;

Vextraction = volume extraction solvent added (e.g. mL);

wflour = weight flour used (e.g. g).

In this particular study, Calculation (3.3) becomes:

Page 34: The behaviour of deoxynivalenol and deoxynivalenol-3 ...lib.ugent.be/fulltxt/RUG01/002/063/851/RUG01-002063851_2013_0001_AC.pdf · is, however, the possibility that deoxynivalenol-3-glucoside

25

𝐿𝑜𝑋 (µ𝑔/𝑔) = 𝐿𝑜𝑋 (𝑛𝑔/𝑚𝐿)∗2∗4 (𝑚𝐿)

200 (𝑚𝑔) (3.4)

The recovery of the samples was calculated based on the standard series equation of the

entire experiment if possible (i.e. a regression coefficient above 0.9800). If the regression

coefficient (R2) did not exceed this value, bracketing was used: the equation used was based

only on the two standard series injected in time closest to the sample. For all calculations,

MassLynx NTTM (Waters, Dublin, Ireland) and Microsoft Excel (Microsoft, Reading, UK)

were used.

Page 35: The behaviour of deoxynivalenol and deoxynivalenol-3 ...lib.ugent.be/fulltxt/RUG01/002/063/851/RUG01-002063851_2013_0001_AC.pdf · is, however, the possibility that deoxynivalenol-3-glucoside

26

4. RESULTS

4.1. OPTIMISATION OF THE EXTRACTION METHOD

The following extraction methods were investigated on spiked flour (see Figure 4.1):

Buffer;

Acetonitrile and buffer (80:20, v:v);

Acetonitrile and buffer (80:20, v:v) with QuEChERS;

Acetonitrile and buffer (80:20, v:v) with QuEChERS with subsequent evaporation and

redissolution in eluent A;

Acetonitrile and buffer (50:50, v:v);

Acetonitrile and buffer (50:50, v:v) with subsequent evaporation and redissolution in

eluent A;

Acetonitrile and buffer (50:50, v:v) with 1:1 (v:v) dilution with water before injection.

The use of buffer only gave low recoveries and was discarded. The buffer-acetonitrile

combination gave good results, but showed fronting. The same was observed with the

QuEChERS method, which did not show good phase separation in the solutions. An attempt

was made to heighten the recovery and lower the fronting of peaks in the latter method by

evaporating and redissolving in eluent A. This indeed helped for DON, however not for D3G.

Therefore, this method was also not continued.

0

20

40

60

80

100

120

Buffer QuEChERS QuEChERS

with

evaporation

ACN:buffer

(80:20)

ACN:buffer

(50:50)

ACN:buffer

(50:50) with

dilution

ACN:buffer

(50:50) with

evaporation

Rec

ov

ery

(%

)

DON D3G

Figure 4.1: Summary of researched possible extraction methods used on spiked flour. The amount of

D3G recovered in both QuEChERS methods was under the LoD.

Page 36: The behaviour of deoxynivalenol and deoxynivalenol-3 ...lib.ugent.be/fulltxt/RUG01/002/063/851/RUG01-002063851_2013_0001_AC.pdf · is, however, the possibility that deoxynivalenol-3-glucoside

27

The decision to use the extraction method acetonitrile and buffer (50:50, v:v) with 1:1 (v:v)

dilution before injection with water was based both on the recovery of DON and D3G and the

shape of the peaks. The 1:1 (v:v) dilution gave far less fronting in their peaks than the

undiluted samples and the recovery of D3G was better. In Figure 4.2 an MRM-chromatogram

is illustrated.

Figure 4.2: Total ion chromatogram (TIC) of two flour samples (no enzymes), one spiked with

DON (above) and one spiked with D3G (below).

Page 37: The behaviour of deoxynivalenol and deoxynivalenol-3 ...lib.ugent.be/fulltxt/RUG01/002/063/851/RUG01-002063851_2013_0001_AC.pdf · is, however, the possibility that deoxynivalenol-3-glucoside

28

4.2. OPTIMISATION OF THE MATRIX DIGESTION

Several flour samples and blanks were spiked with DON, D3G, both or none. To these

samples proteinase K, α-amylase, lipase, all enzymes or none were added. To some of the

samples, digested with all the enzymes, laminarinase was added after digestion.

With the acetonitrile-buffer (50:50, v:v) extraction with 1:1 (v:v) dilution before injection,

it became clear traces of DON was present in the flour used, even without spiking, possibly

due to natural contamination of the flour. The exact amount could not be measured, as it was

below to the LoQ. If any D3G was present, it was below the LoD. It should also be noted that

the D3G reference standard contained a small amount of DON, though again below the LoQ

at the normal spiking level.

4.2.1. Recovery of DON

The results of the effect of the matrix digestion on the recovery of DON is summarised in

Figure 4.3.

The presence of the enzymes seems to lower the DON detected instead of increasing it.

The LoD en LoQ for DON were relatively stable throughout the experiments. The LoD

0

10

20

30

40

50

60

70

80

90

no enzymes proteinase K α-amylase lipase all enzymes

Rec

ov

ery

(%

)

DON spike in flour DON spike in blank

DON and D3G spike in flour DON and D3G spike in blank

Figure 4.3: Summary of the DON recovery after spiking. DON was either spiked alone or with D3G.

All tests were performed in double. The term ‘blank’ means no flour was present in the sample.

Page 38: The behaviour of deoxynivalenol and deoxynivalenol-3 ...lib.ugent.be/fulltxt/RUG01/002/063/851/RUG01-002063851_2013_0001_AC.pdf · is, however, the possibility that deoxynivalenol-3-glucoside

29

fluctuated around 3 ng/mL and the LoQ about 10 ng/mL. The samples to which proteinase K

and all enzymes were added gave comparable results.

In the samples where only D3G was present as standard and enzymes were added, amounts

of DON were found (Figure 4.4). They were all above the LoQ, though still close to this

value. The recovery of D3G was not influenced in these instances.

4.2.2. Recovery of D3G

The effect of enzyme matrix digestion on the recovery of D3G for separate and all

enzymes together is summarised in Figure 4.5. The recovery in the spiked sample not

containing enzymes was below the LoQ. A part of the samples (no enzymes and all enzymes)

was therefore remade in a smaller experiment and now the recovery was much higher (Figure

4.6). LoD and LoQ were relatively stable: the LoD was approximately 5 ng/mL and the LoQ

13 ng/mL.

Though D3G could be detected when the standard series in buffer solution was injected

within two days of manufacture, the series showed no D3G presence when injected about a

week after manufacture. This happened twice in the course of the investigation. Several MS

0

0,1

0,2

0,3

0,4

0,5

0,6

0,7

blank proteinase K α-amylase lipase all enzymes all enzymes +

laminarinase

ab

solu

te a

mo

un

t (n

mo

l)

DON D3G

Figure 4.4: Summary of the absolute amount of DON and D3G found in samples that were spiked

with only D3G. In the blank the amount of DON was under the LoD. All tests were performed in

double.

Page 39: The behaviour of deoxynivalenol and deoxynivalenol-3 ...lib.ugent.be/fulltxt/RUG01/002/063/851/RUG01-002063851_2013_0001_AC.pdf · is, however, the possibility that deoxynivalenol-3-glucoside

30

fragment ion scans and a parent ion scan was performed to research this problem, but no other

adduct ions or different parent ions were found.

0

10

20

30

40

50

60

70

80

no enzymes proteinase K α-amylase lipase all enzymes

Rec

over

y (

%)

D3G spike in flour D3G spike in blank DON/D3G spike in flour DON/D3G spike in blank

0

20

40

60

80

100

120

140

160

180

flour without enzymes blank without enzymes flour with all enzymes blank with all enzymes

Rec

ov

ery

(%

)

first experiment second experiment

Figure 4.5: Summary of D3G recovery after spiking. D3G was either added alone or with DON. All

experiments were performed in double. The recovery for D3G alone in flour with no enzymes added

was below the LoD.

Figure 4.6: Comparison of two experiments to establish the recovery for D3G. D3G was spiked

alone. All experiments were performed in double. The recovery for D3G in flour with no enzymes

added in the first experiment was below the LoD.

Page 40: The behaviour of deoxynivalenol and deoxynivalenol-3 ...lib.ugent.be/fulltxt/RUG01/002/063/851/RUG01-002063851_2013_0001_AC.pdf · is, however, the possibility that deoxynivalenol-3-glucoside

31

The laminarinase did not seem to work when added after digestion under the circumstances

described earlier (see 3.3.1. and Figure 4.7). Even though a smaller amount of D3G was

found when laminarinase was added to flour spiked with DON and D3G, this was not

accompanied by a rise in DON as expected. Therefore a small experiment was set up to

optimise the experiment circumstances. The pH of a small volume buffer was lowered to 6

and 5. The laminarinase was incubated with for 30 minutes at 37 °C at either pH 5, 6 or 7.4

and no other enzymes were added. Samples either contained flour or no matrix (blanks). No

effect was found. The recovery for D3G was comparable to the samples without laminarinase

(see Table 4.1): This amount was estimated between 120% to 140% for both flour and blank

samples.

D3G in flour (%) D3G in blank (%)

pH 5 108.0 ± 10.1 115.9 ± 4.3

pH 6 115.6 ± 4.6 115.6 ± 11.4

pH 7.4 117.2 ± 6.4 114.7 ± 7.4

0

10

20

30

40

50

60

70

80

90

DON spiked D3G spiked DON in DON/D3G

spiked

D3G in DON/D3G

spiked

Rec

ov

ery

(%

)

all enzymes in blank all enzymes and laminarinase in blank

all enzymes in flour all enzymes and laminarinase in flour

Table 4.1: Comparison of the recovery for D3G when laminarinase was added at different pH values.

Results are given as recovery ± standard deviation. All tests were performed in triple.

Figure 4.7: Comparison of the recoveries for DON and D3G when laminarinase is or is not present

after matrix digestion. All experiments were performed in double.

Page 41: The behaviour of deoxynivalenol and deoxynivalenol-3 ...lib.ugent.be/fulltxt/RUG01/002/063/851/RUG01-002063851_2013_0001_AC.pdf · is, however, the possibility that deoxynivalenol-3-glucoside

32

5. DISCUSSION

5.1. EXTRACTION METHOD

Research was mainly focussed on the optimisation of the extraction method and several

possibilities were taken into account. Most of them were based on a mix of acetonitrile and

buffer solution as basis, as literature showed a preference for mixes of acetonitrile and water.

Though QuEChERS was attempted, it was not used as the final extraction method, as

recovery was low for DON to non-existent for D3G. The latter might be too polar to move to

the acetonitrile separate phase that ought to arise, as literature has suggested (Cirlini et al.,

2012, Dall'Asta et al., 2012).

The recovery of D3G changed overtime. During the first experiments, it was estimated on

60% to 70% at best. When some experiments were repeated, however, the recovery rose to

approximately 120%. No explanation for this phenomenon was found, though it might be

linked to another strange occurrence: the apparent destruction of D3G in the standard series

prepared in buffer solution. Several MS scans were performed on the standard with the

highest level to find possible degradation or fragment ions, but none were found. Also, a

parent ion scan was performed to observe possible different parent ions (normally mainly the

acetate adducts were focussed upon) with again no results. It might be possible that these

were present but not detected. The Micromass Quattro Ultima PT is more suited as a

quantification instrument than as an identification instrument. A possible cause is an

interaction with a chemical in the buffer solution, but since the standard series had been

prepared before in buffer solution without apparent problems, it seems unlikely that this was

the only cause. Another possibility is the HPLC vials used, as these were changed to another

type a few days before the standard series that first showed this problem were prepared.

Again, it seems unlikely that this was the only cause. It might be that these two possibilities

enhanced one another, however, speeding the process up. Possibly, the same process was

responsible for the change in recovery during the study. No suggested cause could be pointed

as the only possibility however. This could either be researched further, or it must be

attempted to measure samples containing D3G as soon as possible after preparation.

As explained under 3.4.5, several calculations for the LoD and LoQ can be used. When the

LoDs and LoQs found in this study are converted to w:w values (see Calculation 3.4), as can

be found in literature, the following values can be found: 0.12 µg/g and 0.40 µg/g resp. for

DON and 0.20 µg/g and 0.52 µg/g resp. for D3G. In comparison to the values found in

literature (for examples see Tables 1.1 to 1.3), these are rather high: most values in literature

can be found in the µg/kg order of magnitude. The calculation used in this study is much more

Page 42: The behaviour of deoxynivalenol and deoxynivalenol-3 ...lib.ugent.be/fulltxt/RUG01/002/063/851/RUG01-002063851_2013_0001_AC.pdf · is, however, the possibility that deoxynivalenol-3-glucoside

33

conservative than the more common signal-to-noise ratio however. Thus, the values found in

this study and those found in literature are not truly comparable. Additionally, the original

sample was diluted several times. While the amounts measured in the standard series are

rather low, when they are converted to w:w values, they seem much higher. Also, most

studies use, as mentioned above, a mix of acetonitrile and water as their extraction solvent,

while here a buffer solution was used instead of water. When the response of the standard

series in eluent A was compared to the response in buffer solution, it was clear that the latter’s

response was lower than the former’s. The ions present in the buffer solution seem to lower

the response of the analytes, which made determination of low amounts difficult. It must also

be stressed that no method validation was performed and the LoD and LoQ varied dependent

of the exact standard series injection.

5.2. ENZYME MATRIX DIGESTION

The enzyme digestion step was added to the sample preparation to extract and quantify

bound mycotoxins, either already present in the flour or captured there during processing.

Though no conclusions could be drawn regarding other matrices, e.g. dough or bread,

enzymatic matrix digestion did not seem fit for flour. DON and D3G recoveries were the

highest when no enzymes are present and the presence of proteinase K in particular seemed to

heighten the interference, which complicated the integration of the peak surfaces.

When looking at the differences between the enzymes, it could be noted that the recovery

when the proteinase K was used was comparable to the recovery of those samples where all

enzymes were used. This suggested that proteinase K might hydrolyse the other enzymes in

the mix. This suggestion was backed up by the fact that proteinase K is often used to

hydrolyse other enzymes and might destroy both α-amylase and lipase. It would perhaps be

useful to in future therefore use only the individual enzymes and to never add them all

together in future experiments.

Laminarinase was an enzyme that was discovered to be able to hydrolyse D3G to DON

and a glucose molecule in an unpublished study undertaken at Wageningen University. The

goal of its use in this study was to establish the sum of DON and D3G present so that if the

recovery of D3G was lower than the recovery of DON, this could perhaps be corrected.

Unfortunately, laminarinase did not seem to work under the given circumstances, though an

attempt to optimise the pH was made. Originally the enzyme was only used at pH 7.4, but in

the unpublished study the pH was 5. Therefore the pH was lowered to 6 and 5 and the

experiment was repeated. This did not activate the enzyme. The temperature (37 °C) was the

Page 43: The behaviour of deoxynivalenol and deoxynivalenol-3 ...lib.ugent.be/fulltxt/RUG01/002/063/851/RUG01-002063851_2013_0001_AC.pdf · is, however, the possibility that deoxynivalenol-3-glucoside

34

same as in the unpublished study and the time of incubation as well. Glucose was an inhibitor

of laminarinase and this could explain its lack of activity in samples containing flour.

However, no activity was found in the blank samples which did not contain flour. It was thus

unlikely that glucose inhibited the enzyme. There might be another chemical present in the

buffer solution that caused the inhibition of activity. The buffer used in the unpublished study

was less complex than the solution we used and, except for glucose, no other information

about possible inhibitors was given. It is possible that one of the salts contained an ion that

inhibited the enzyme.

A small amount of DON, below the LoQ, could be detected in the unspiked flour. This

amount seemed slightly higher when only D3G was spiked, which suggested the presence of a

small amount of DON present in the D3G standard. Again the amount of DON seemed higher

when enzymes were present: it could now be actually measured, as it exceeded the LoQ. As

the recovery of D3G remained stable, a possible explanation is the undetected presence of a

bound form of DON in the matrix, which is freed by the enzymes. One must be careful

however to draw this conclusion. Though the amount exceeded the LoQ, it was still very near

to it and the value has therefore a high uncertainty. Plus, the DON detected in the flour when

no enzymes were present did not seem to differ from the amount of DON found when all

enzymes were present: both were below the LoQ. It might be possible that the presence of

DON in both the flour and the D3G standard, together with fluctuations in the mass

spectrometer, caused the exceeding of the LoQ.

Page 44: The behaviour of deoxynivalenol and deoxynivalenol-3 ...lib.ugent.be/fulltxt/RUG01/002/063/851/RUG01-002063851_2013_0001_AC.pdf · is, however, the possibility that deoxynivalenol-3-glucoside

35

6. CONCLUSIONS

The goal of this study was to ascertain the fate of DON and D3G when present in flour that

is made into bread. To make certain that all forms of DON, whether they were free, bound or

conjugated and extractable, would be detected, the possibility of enzymatic matrix digestion

was researched. Because several preparation steps took longer than was previously assumed,

only the extraction method and enzyme matrix digestion were researched. The rest of the

study would have to be continued later.

The extraction method with the highest recoveries for both DON and D3G as well as the

least interference was chosen. This was a mix of acetonitrile and buffer solution in a 50:50

(v:v) relationship with a 1:1 (v:v) dilution with water before injection. Recovery was 70% to

80% for DON.

The recovery for D3G nearly doubled in the course of this study. At the same time, it was

discovered that D3G seemed to get destroyed in the standard series prepared in buffer solution

when it was kept for more than a couple of days. A possibility is the enhancement of a buffer

solution effect by a new type of glassware, but this was not further investigated due to a lack

of time. It might be advisable to measure samples containing D3G as close as possible to

preparation.

A small amount of DON was present in the flour used as matrix. It was below the LoQ and

thus could not be measured. It is not certain if the presence of enzymes might release DON

from the matrix.

Laminarinase, an enzyme that ought to convert D3G to DON and glucose, did not work

under the circumstances used in this part of the study. An unknown inhibitor in the buffer

solution might be the cause.

The enzyme matrix digestion did not result in higher recoveries when used on flour

matrices. More than that, interference was higher when proteinase K was present. It was also

suspected that this enzyme might destroy the other enzymes present. Thus, it might be more

economical to no longer add all enzymes together to samples, as this gives no further

information.

In the next part of the study, several stadia in the breadmaking process will be examined,

e.g. dough, kneaded dough, proofed dough and bread itself. It might be necessary to adapt the

sample preparation to each of these stadia, as the matrix will have changed after every step.

Likewise, it might be feasible to use enzymatic matrix digestion on one of these steps, even if

it does not add to the results of the starting product, i.e. the flour. If it turns out enzymatic

matrix digestion is not suited for this kind of research at all, it might be considered to change

Page 45: The behaviour of deoxynivalenol and deoxynivalenol-3 ...lib.ugent.be/fulltxt/RUG01/002/063/851/RUG01-002063851_2013_0001_AC.pdf · is, however, the possibility that deoxynivalenol-3-glucoside

36

the buffer solution used in the extraction solvent to water. This will make the response on the

mass spectrometer rise and might have a positive effect on the conservation of samples

containing D3G. It might be advisable nevertheless to measure those samples containing D3G

as soon as possible after preparation.

Page 46: The behaviour of deoxynivalenol and deoxynivalenol-3 ...lib.ugent.be/fulltxt/RUG01/002/063/851/RUG01-002063851_2013_0001_AC.pdf · is, however, the possibility that deoxynivalenol-3-glucoside

37

7. LITERATURE LIST/REFERENCES

Abbas, H. K., C. J. Mirocha, R. J. Pawlosky and D. J. Pusch (1985). "Effect of cleaning,

milling, and baking on deoxynivalenol in wheat." Applied and Environmental Microbiology

50(2): 482-486.

Abdel-Aal, E.-S. M., K. Miah, J. Christopher Young and I. Rabalski (2007). "Comparison of

four C18 columns for the liquid chromatographic determination of deoxynivalenol in

naturally contaminated wheat." Journal of AOAC International 90(4): 995-999.

Bergamini, E., D. Catellani, C. Dall'asta, G. Galaverna, A. Dossena, R. Marchelli and M.

Suman (2010). "Fate of fusarium mycotoxins in the cereal product supply chain: The

deoxynivalenol (DON) case within industrial bread-making technology." Food Additives and

Contaminants - Part A Chemistry, Analysis, Control, Exposure and Risk Assessment 27(5):

677-687.

Berthiller, F., C. Crews, C. Dall'Asta, S. De Saeger, G. Haesaert, P. Karlovsky, I. P. Oswald,

W. Seefelder, G. Speijers and J. Stroka (2013). "Masked mycotoxins: A review." Molecular

Nutrition and Food Research 57(1): 165-186.

Berthiller, F., C. Dall'Asta, R. Schuhmacher, M. Lemmens, G. Adam and R. Krska (2005).

"Masked mycotoxins: Determination of a deoxynivalenol glucoside in artificially and

naturally contaminated wheat by liquid chromatography-tandem mass spectrometry." Journal

of Agricultural and Food Chemistry 53(9): 3421-3425.

Berthiller, F., R. Krska, K. J. Domig, W. Kneifel, N. Juge, R. Schuhmacher and G. Adam

(2011). "Hydrolytic fate of deoxynivalenol-3-glucoside during digestion." Toxicology Letters

206(3): 264-267.

Bhat, R., Y. Ramakrishna, S. R. Beedu and K. L. Miunshi (1989). "Outbreak of trichothecene

mycotoxicosis associated with consumption of mould-damaged wheat products in Kashmir

Valley, India." Lancet 1(8628): 35-37.

Boyacioglu, D., N. S. Hettiarachchy and B. L. D'Appolonia (1993). "Additives Affect

Deoxynivalenol (Vomitoxin) Flour during Breadbaking." Journal of Food Science 58(2): 416-

418.

BRENDA - The Comprehensive Enzyme Information System. EC 3.1.1.3 - triacylglycerol

lipase, Technische Universität Braunschweig. url: http://www.brenda-enzymes.org/

(consulted on 20-02-2013)

BRENDA - The Comprehensive Enzyme Information System. EC 3.2.1.1 - alpha-amylase,

Technische Universität Braunschweig. url: http://www.brenda-enzymes.org/ (consulted on 20-

02-2013)

Bretz, M., M. Beyer, B. Cramer, A. Knecht and H.-U. Humpf (2006). "Thermal degradation

of the Fusarium mycotoxin deoxynivalenol." Journal of Agricultural and Food Chemistry

54(17): 6445-6451.

Buehler, E. (2005). Chapter 2: Bread science basics. Bread Science: the Chemistry and Craft

of Making Bread. Carrboro, North Carolina, Two Blue Books.

Caporael, L. (1976). "Ergotism: the Satan loosed in Salem?" Science 192(4234): 21-26.

Cirlini, M., C. Dall’Asta and G. Galaverna (2012). “Hyphenated chromatographic techniques

for structuram characterization and determination of masked mycotoxins.” Journal of

Chromatography A 1255: 145-152.

Connelly, A. (2009). The science and magic of breadmaking. The Guardian.

Page 47: The behaviour of deoxynivalenol and deoxynivalenol-3 ...lib.ugent.be/fulltxt/RUG01/002/063/851/RUG01-002063851_2013_0001_AC.pdf · is, however, the possibility that deoxynivalenol-3-glucoside

38

Dall'Asta, C., A. Dall'Erta, P. Mantovani, A. Massi and G. Galaverna (2013). "Occurrence of

deoxynivalenol and deoxynivalenol-3-glucoside in durum wheat." World Mycotoxin Journal

6(1): 83-91.

de Angelis, E., L. Monaci, M. Pascale and A. Visconti (2013). "Fate of deoxynivalenol, T-2

and HT-2 toxins and their glucoside conjugates from flour to bread: an investigation by high-

performance liquid chromatography high-resolution mass spectrometry." Food Additives and

Contaminants - Part A Chemistry, Analysis, Control, Exposure and Risk Assessment 30(2):

345-355.

De Boevre, M., J. D. Di Mavungu, P. Maene, K. Audenaert, D. Deforce, G. Haesaert, M.

Eeckhout, A. Callebaut, F. Berthiller, C. Van Peteghem and S. De Saeger (2012).

"Development and validation of an LC-MS/MS method for the simultaneous determination of

deoxynivalenol, zearalenone, T-2-toxin and some masked metabolites in different cereals and

cereal-derived food." Food Additives and Contaminants - Part A Chemistry, Analysis,

Control, Exposure and Risk Assessment 29(5): 819-835.

De Nijs, M., H. J. Van Den Top, L. Portier, G. Oegema, E. Kramer, H. P. Van Egmond and L.

A. P. Hoogenboom (2012). "Digestibility and absorption of deoxynivalenol-3-ß-glucoside in

in vitro models." World Mycotoxin Journal 5(3): 319-324.

de Souza, P. M. and P. O. e Magalhães (2010). "Application of microbial α-amylase in

industry - a review." Brazilian Journal of Microbiology 41(4): 850-861.

Desmarchelier, A. and W. Seefelder (2010). "Survey of deoxynivalenol and deoxynivalenol-

3-glucoside in cereal-based products by liquid chromatography electrospray ionization

tandem mass spectrometry." World Mycotoxin Journal 4(1): 29-35.

El Banna, A. A., P. Y. Lau and P. M. Scott (1983). "Fate of mycotoxins during processing of

foodstuffs II. Deoxynivalenol (vomitoxin) during making of Egyptian bread." Journal of Food

Protection 46(6): 484-486.

European Commission (2006). “Setting maximum levels for certain contaminants in

foodstuffs.” Commission regulation 1881/2006.

Feuell, A. J. (1966). "Toxic Factors of Mould Origin." Canadian Medical Association Journal

94(12): 574-581.

Goesaert, H., L. Slade, H. Levine and J. A. Delcour (2009). "Amylases and bread firming - an

integrated view." Journal of Cereal Science 50(3): 345-352.

Gomes-Ruffi, C. R., R. H. D. Cunha, E. L. Almeida, Y. K. Chang and C. J. Steel (2012).

"Effect of the emulsifier sodium stearoyl lactylate and of the enzyme maltogenic amylase on

the quality of pan bread during storage." LWT - Food Science and Technology 49(1): 96-101.

Goryacheva, I.Y. and S. De Saeger (2012). “Immunochemical detection of masked

mycotoxins: a short review.” World Mycotoxin Journal 5(3): 281-287.

International Agency for Research on Cancer (1993). “Toxins Derived from Fusarium

Graminearum, F. Culmorum and F. Crookwellense: Zearalenone, Deoxynivalenol, Nivalenol

and Fusarenone X.” IARC Monographs on the Evaluation of Carcinogenic Risks to Humans

56: 397-444.

International Union of Biochemistry and Molecular Biology (1961). EC 3.1.1.3. IUBMB

Enzyme Nomenclature. url: http://www.iubmb.org/ (consulted on 20-02-2013)

International Union of Biochemistry and Molecular Biology (1961). EC 3.2.1.1. IUBMB

Enzyme Nomenclature. url: http://www.iubmb.org/ (consulted on 20-02-2013)

Page 48: The behaviour of deoxynivalenol and deoxynivalenol-3 ...lib.ugent.be/fulltxt/RUG01/002/063/851/RUG01-002063851_2013_0001_AC.pdf · is, however, the possibility that deoxynivalenol-3-glucoside

39

International Union of Biochemistry and Molecular Biology (1992). EC 3.4.21.64. IUBMB

Enzyme Nomenclature. url: http://www.iubmb.org/ (consulted on 20-02-2013)

JECFA report (2010). Deoxynivalenol. Joint FAO/WHO Expert Commitee of Food

Additives, FAO/WHO.

Kostelanska, M., Z. Dzuman, A. Malachova, I. Capouchova, E. Prokinova, A. Skerikova and

J. Hajslova (2011). "Effects of milling and baking technologies on levels of deoxynivalenol

and its masked form deoxynivalenol-3-glucoside." Journal of Agricultural and Food

Chemistry 59(17): 9303-9312.

Kushiro, M. (2008). "Effects of milling and cooking processes on the deoxynivalenol content

in wheat." International Journal of Molecular Sciences 9(11): 2127-2145.

Lancova, K., J. Hajslova, M. Kostelanska, J. Kohoutkova, J. Nedelnik, H. Moravcova and M.

Vanova (2008). "Fate of trichothecene mycotoxins during the processing: milling and

baking." Food Additives and Contaminants - Part A Chemistry, Analysis, Control, Exposure

and Risk Assessment 25(5): 650-659.

Lattanzio, V. M. T., S. D. Gatta, M. Suman and A. Visconti (2011). "Development and in-

house validation of a robust and sensitive solid-phase extraction liquid

chromatography/tandem mass spectrometry method for the quantitative determination of

aflatoxins B 1, B 2, G 1, G 2, ochratoxin A, deoxynivalenol, zearalenone, T-2 and HT-2

toxins in cereal-based foods." Rapid Communications in Mass Spectrometry 25(13): 1869-

1880.

Lauren, D. R. and W. A. Smith (2001). "Stability of the Fusarium mycotoxins nivalenol,

deoxynivalenol and zearalenone in ground maize under typical cooking environments." Food

Additives and Contaminants 18(11): 1011-1016.

Lešnik, M., A. Cencič, S. Vajs and A. Simončič (2008). "Milling and bread baking techniques

significantly affect the mycotoxin (deoxynivalenol and nivalenol) level in bread." Acta

Alimentaria 37(4): 471-483.

Lessinger, J.-M., G. Férard, V. Mignot, D. H. Calam, R. Gaines Das and J.-L. Dourson

(1996). "Catalytic properties and stability of lipase purified from human pancreatic juice."

Clinica Chimica Acta 251(2): 119-129.

MacDonald, S. J., D. Chan, P. Brereton, A. Damant, R. Wood, K. Dao Duy, I. Felgueiras, T.

Feron, M.-P. Herry, E. Ioannou-Kakouri, P. Koch, R. Krska, P. Majerus, J. Nesbit, M. Reuter,

S. Stangroom, P. Symonds and R. Weber (2005). "Determination of deoxynivalenol in cereals

and cereal products by immunoaffinity column cleanup with liquid chromatography:

Interlaboratory study." Journal of AOAC International 88(4): 1197-1204.

Meneely, J.P., F. Ricci, H.P. Van Egmond and C.T. Elliot (2011). “Current methods of

analysis for the determiation of trichothecene mycotoxins in food.” Trends in Analytical

Chemistry 30(2): 192-203.

Miller, J. D. (1995). "Fungi and Mycotoxins in Grain: Implications for Stored Product

Research." Journal of Stored Products Research 31(1): 1-16.

Monaci, L., E. De Angelis and A. Visconti (2011). "Determination of deoxynivalenol, T-2

and HT-2 toxins in a bread model food by liquid chromatography-high resolution-Orbitrap-

mass spectrometry equipped with a high-energy collision dissociation cell." Journal of

Chromatography A 1218(48): 8646-8654.

Page 49: The behaviour of deoxynivalenol and deoxynivalenol-3 ...lib.ugent.be/fulltxt/RUG01/002/063/851/RUG01-002063851_2013_0001_AC.pdf · is, however, the possibility that deoxynivalenol-3-glucoside

40

Nagl, V., H. Schwartz, R. Krska, W.D. Moll, S. Knasmüller, M. Ritzmann, G. Adam and F.

Berthiller (2012). “Metabolism of the masked mycotoxin deoxynivalenol-3-glucoside in rats.”

Toxicology Letters 213(3): 367-373.

Neumann, G., G. A. Lombaert, S. Kotello and N. Fedorowich (2009). "Determination of

deoxynivalenol in soft wheat by immunoaffinity column cleanup and LC-UV detection:

interlaboratory study." Journal of AOAC International 92(1): 181-189.

Numanoglu, E., V. Gökmen, U. Uygun and H. Koksel (2012). "Thermal degradation of

deoxynivalenol during maize bread baking." Food Additives and Contaminants - Part A

Chemistry, Analysis, Control, Exposure and Risk Assessment 29(3): 423-430.

Osseyi, E. S., R. L. Wehling and J. A. Albrecht (1998). "Liquid chromatographic method for

determining added folic acid in fortified cereal products." Journal of Chromatography A

826(2): 235-240.

Pacin, A., E. Ciancio Bovier, G. Cano, D. Taglieri and C. Hernandez Pezzani (2010). "Effect

of the bread making process on wheat flour contaminated by deoxynivalenol and exposure

estimate." Food Control 21(4): 492-495.

Pestka, J. J. (2010). "Deoxynivalenol: mechanisms of action, human exposure, and

toxicological relevance." Archives of Toxicology 84(9): 663-679.

Ragab, W. S. M., S. Drusch, A. Kuhlmann and M. Beyer (2005). "Characterizing effects of

fermentation and baking on the deoxynivalenol content of rolls." Journal of Applied Botany

and Food Quality 79(3): 197-201.

Reuben, B. and T. Coultate (2009). "On the rise." Chemistry World 6(10): 54-57.

Ryu, D., A. Bianchini and L. B. Bullerman (2008). "Effects of processing on mycotoxins."

Stewart Postharvest Review 4(6): 1-7.

Samar, M. M., M. S. Neira, S. L. Resnik and A. Pacin (2001). "Effect of fermentation on

naturally occurring deoxynivalenol (DON) in Argentinean bread processing technology."

Food Additives and Contaminants 18(11): 1004-1010.

Sano, A., S. Matsutani, M. Suzuki and S. Takitani (1987). "High-performance liquid

chromatographic method for determining trichothecene mycotoxins by post-column

fluorescence derivatization." Journal of Chromatography A 410(C): 427-436.

SCOOP (2003). “Collection of occurence data of Fusarium toxins in food and assessment of

dietary intake by the population of EU member states.” SCOOP Task 3.2.10. Directory-

General Health and Consumer Protection.

Scott, P. M., S. R. Kanhere, J. E. Dexter, P. W. Brennan and H. L. Trenholm (1984).

"Distribution of the trichothecene mycotoxin deoxynivalenol (vomitoxin) during the milling

of naturally contaminated hard red spring wheat and its fate in baked products." Food

Additives and Contaminants 1(4): 313-323.

Scudamore, K. A., C. M. Hazel, S. Patel and F. Scriven (2009). "Deoxynivalenol and other

Fusarium mycotoxins in bread, cake, and biscuits produced from uk-grown wheat under

commercial and pilot scale conditions." Food Additives and Contaminants - Part A

Chemistry, Analysis, Control, Exposure and Risk Assessment 26(8): 1191-1198.

Simsek, S., K. Burgess, K.L. Whitney, Y. Gu and S.Y. Qian (2012). “Analysis of

Deoxynivalenol and Deoxynivalenol-3-Glucoside in wheat.” Food Control 26(2): 287-292.

Solfrizzo, M., L. Gambacorta, V. M. T. Lattanzio, S. Powers and A. Visconti (2011).

"Simultaneous LC-MS/MS determination of aflatoxin M 1, ochratoxin A, deoxynivalenol, de-

Page 50: The behaviour of deoxynivalenol and deoxynivalenol-3 ...lib.ugent.be/fulltxt/RUG01/002/063/851/RUG01-002063851_2013_0001_AC.pdf · is, however, the possibility that deoxynivalenol-3-glucoside

41

epoxydeoxynivalenol, α- and β-zearalenols and fumonisin B1 in urine as a multi-biomarker

method to assess exposure to mycotoxins." Analytical and Bioanalytical Chemistry 401(9):

2831-2841.

Spanos, N. P. and J. Gottlieb (1976). "Ergotism and the Salem Village witch trials." Science

194(4272): 1390-1394.

Sugita-Konishi, Y., B. J. Park, K. Kobayashi-Hattori, T. Tanaka, T. Chonan, K. Yoshikawa

and S. Kumagai (2006). "Effect of cooking process on the deoxynivalenol content and its

subsequent cytotoxicity in wheat products." Bioscience, Biotechnology and Biochemistry

70(7): 1764-1768.

Suman, M., E. Bergamini, D. Catellani and A. Manzitti (2013). "Development and validation

of a liquid chromatography/linear ion trap mass spectrometry method for the quantitative

determination of deoxynivalenol-3- glucoside in processed cereal-derived products." Food

Chemistry 136(3-4): 1568-1576.

Suman, M., A. Manzitti and D. Catellani (2012). "A design of experiments approach to

studying deoxynivalenol and deoxynivalenol-3-glucoside evolution throughout industrial

production of wholegrain crackers exploiting LC-MS/MS techniques." World Mycotoxin

Journal 5(3): 241-249.

Sweeney, P. J. and J. M. Walker (1993). Proteinase K (EC 3.4.21.14). Enzymes of Molecular

Biology. M. M. Burrell, Humana Press. 16.

Tran, S. T. and T. K. Smith (2011). "Determination of optimal conditions for hydrolysis of

conjugated deoxynivalenol in corn and wheat with trifluoromethanesulfonic acid." Animal

Feed Science and Technology 163(2-4): 84-92.

Tran, S. T., T. K. Smith and G. N. Girgis (2012). "A survey of free and conjugated

deoxynivalenol in the 2008 corn crop in Ontario, Canada." Journal of the Science of Food and

Agriculture 92(1): 37-41.

Turner, P. C. (2010). "Deoxynivalenol and nivalenol occurrence and exposure assessment."

World Mycotoxin Journal 3(4): 315-321.

Turnera, P. C., R. P. Hopton, Y. Lecluse, K. L. M. White, J. Fisher and P. Lebailly (2010).

"Determinants of urinary deoxynivalenol and de-epoxy deoxynivalenol in male farmers from

Normandy, France." Journal of Agricultural and Food Chemistry 58(8): 5206-5212.

Turner, P. C., R. P. Hopton, K. L. M. White, J. Fisher, J. E. Cade and C. P. Wild (2011).

"Assessment of deoxynivalenol metabolite profiles in UK adults." Food and Chemical

Toxicology 49(1): 132-135.

Turnerb, P. C., B. T. Ji, X. O. Shu, W. Zheng, W. H. Chow, Y. T. Gao and L. J. Hardie

(2011). "A biomarker survey of urinary deoxynivalenol in China: The Shanghai women's

health study." Food Additives and Contaminants - Part A Chemistry, Analysis, Control,

Exposure and Risk Assessment 28(9): 1220-1223.

Valle-Algarra, F. M., E. M. Mateo, Á. Medina, F. Mateo, J. V. Gimeno-Adelantado and M.

Jiménez (2009). "Changes in ochratoxin A and type B trichothecenes contained in wheat flour

during dough fermentation and bread-baking." Food Additives and Contaminants - Part A

Chemistry, Analysis, Control, Exposure and Risk Assessment 26(6): 896-906.

Van Der Maarel, M. J. E. C., B. Van Der Veen, J. C. M. Uitdehaag, H. Leemhuis and L.

Dijkhuizen (2002). "Properties and applications of starch-converting enzymes of the α-

amylase family." Journal of Biotechnology 94(2): 137-155.

Page 51: The behaviour of deoxynivalenol and deoxynivalenol-3 ...lib.ugent.be/fulltxt/RUG01/002/063/851/RUG01-002063851_2013_0001_AC.pdf · is, however, the possibility that deoxynivalenol-3-glucoside

42

Vendl, O., F. Berthiller, C. Crews and R. Krska (2009). "Simultaneous determination of

deoxynivalenol, zearalenone, and their major masked metabolites in cereal-based food by LC-

MS-MS." Analytical and Bioanalytical Chemistry 395(5): 1347-1354.

Veršilovskis, A., B. Huybrecht, E. K. Tangni, L. Pussemier, S. de Saeger and A. Callebaut

(2011). "Cross-reactivity of some commercially available deoxynivalenol (DON) and

zearalenone (ZEN) immunoaffinity columns to DON- and ZEN-conjugated forms and

metabolites." Food Additives and Contaminants - Part A Chemistry, Analysis, Control,

Exposure and Risk Assessment 28(11): 1687-1693.

Voss, K. A. and M. E. Snook (2010). "Stability of the mycotoxin deoxynivalenol (DON)

during the production of flour-based foods and wheat flake cereal." Food Additives and

Contaminants - Part A Chemistry, Analysis, Control, Exposure and Risk Assessment 27(12):

1694-1700.

Warth, B., M. Sulyok, P. Fruhmann, F. Berthiller, R. Schuhmacher, C. Hametner, G. Adam, J.

Fröhlich and R. Krska (2012). "Assessment of human deoxynivalenol exposure using an LC–

MS/MS based biomarker method." Toxicology Letters 211(1): 85-90.

W.H.O. (1990). Selected mycotoxins: ochratoxins, trichothecenes, ergot. International

Programme on Chemical Safety. Geneva, World Health Organisation.

Young, J. C., R. G. Fulcher, J. H. Hayhoe, P. M. Scott and J. E. Dexter (1984). "Effect of

milling and baking on deoxynivalenol (vomitoxin) content of eastern Canadian wheats."

Journal of Agricultural and Food Chemistry 32(3): 659-664.

Young, J. C., L. M. Subryan, D. Potts, M. E. McLaren and F. H. Gobran (1986). "Reduction

in levels of deoxynivalenol in contaminated wheat by chemical and physical treatment."

Journal of Agricultural and Food Chemistry 34(3): 461-465.

Yu, C., L. D. Penn, J. Hollembaek, W. Li and L. H. Cohen (2004). "Enzymatic Tissue

Digestion as an Alternative Sample Preparation Approach for Quantitative Analysis Using

Liquid Chromatography-Tandem Mass Spectrometry." Analytical Chemistry 76(6): 1761-

1767.

Yumbe-Guevara, B. E., T. Imoto and T. Yoshizawa (2003). "Effects of heating procedures on

deoxynivalenol, nivalenol and zearalenone levels in naturally contaminated barley and

wheat." Food Additives and Contaminants 20(12): 1132-1140.

Zachariasova, M., M. Vaclavikova, O. Lacina, L. Vaclavik and J. Hajslova (2012).

"Deoxynivalenol Oligoglucosides: New "Masked" Fusarium Toxins Occurring in Malt, Beer,

and Breadstuffs." Journal of Agricultural and Food Chemistry 60(36): 9280-9291.

Zangenberg, N. H., A. Müllertz, H. G. Kristensen and L. Hovgaard (2001). "A dynamic in

vitro lipolysis model. I. Controlling the rate of lipolysis by continuous addition of calcium."

European Journal of Pharmaceutical Sciences 14(2): 115-122.

Zhou, B., G. Q. He and P. B. Schwarz (2008). "Occurrence of bound deoxynivalenol in

Fusarium head blight-infected barley (Hordeum vulgare L.) and malt as determined by

solvolysis with trifluoroacetic acid." Journal of Food Protection 71(6): 1266-1269.